Introduction {#Sec1}
============

*Lonicera japonica* Thunberg (Caprifoliaceae), the medicine food homology herb (Hou and Jiang [@CR61]) which has long been applied in treating inflammation and infectious diseases, is pervasively cultivated in eastern Asia, such as China, Japan and Korea (<http://www.efloras.org/>) and was initially introduced to America as a horticultural plant with wind breaker and sand-fixation properties (He et al. [@CR58]). However, it is now believed as a bio-invasion in North America, South America and Oceania (Lloyd et al. [@CR121]). According to '*Ben Cao Gang Mu*' (AD 1552--1578), the herbalism masterpiece which was known as the ancient Chinese encyclopedia, JYH was described as a commonly used herb to treat fever, phyma and sore. Modern pharmacological study has confirmed the antiviral, antibacterial and anti-inflammatory activities of JYH, supporting the traditional applications (Kang et al. [@CR84]; Kao et al. [@CR85]; Shi et al. [@CR161]). Likewise, pharmacological study showed antioxidative, anti-tumour, liver protective and hypoglycemic activities of JYH (Jiang et al. [@CR78]; Kong et al. [@CR89]; Zhao et al. [@CR237]; Park et al. [@CR138]). So far, more than 300 compounds have been isolated and identified from JYH, including phenolic acids, flavonoids, saponins, iridoids, etc. (Yang et al. [@CR218]; Ni [@CR132]; Lin et al. [@CR117]).

JYH is one of the 70 most valuable herbs declared by the State Council of China. There are 312 Chinese patent medicines (CPMs) and 163 domestic health food containing JYH according to the data of National Scientific Data Sharing Platform for Population and Health (<http://www.ncmi.cn/>) and China Food and Drug Administration (CFDA, [www.sfda.gov.cn/](http://www.sfda.gov.cn/)). The standard of JYH was first recorded in Chinese Pharmacopoeia (ChP) in 1963, limiting JYH medicinal part to dried flower buds of *Lonicera japonica* Thunberg. In 1977 Edition ChP, JYH had four plant origins, including *L. japonica*, *Lonicera hypoglauca* Miquel, *Lonicera confusa* DeCandolle and *Lonicera dasystyla* Rehder. Meanwhile, the medicinal parts were dried flower buds or initial flowers. This standard did not change in the subsequent 1985, 1990, 1995, and 2000 Edition ChP. In 2005 Edition ChP, JYH and Lonicerae flos (called Shanyinhua, SYH in Chinese) were listed as two herbs. The plant origin of JYH was changed to be consistent with that of 1963 Edition ChP, being *L. japonica*, while SYH was a multi-origins herb and plant origins were *L. hypoglauca*, *L. confusa* and *Lonicera macranthoides* Handel-Mazzetti. In 2010 Edition ChP, *Lonicera fulvotomentosa* Hsu et Cheng was listed as a new plant origin of SYH. Since then, there have been four plant origins of SYH.

Since JYH and SYH were listed as two herbs, controversies on their quality standards and interchangeability are ceaselessly due to their close proximity on plant species and appearances, together with traditional applications and great homogeneity regarding their medicinal uses. Meanwhile, owing to higher price of JYH, JYH is often adulterated with SYH motivated by economic interests. Furthermore, pharmaceutical companies need to provide scientific evidence to the Pharmacopoeia Committee if they want to change crude materials in CPMs from JYH to SYH (<http://samr.cfda.gov.cn/WS01/CL0844/10570.html>). Last but not least, there is a synonymy problem of SYH plant origins that was not mentioned in ChP. According to ThePlantList and eFloras, *L. macranthoides* and *L*. *fulvotomentosa* are synonymies of *Lonicera macrantha* (D.Don) Spreng, and *L. dasystyla* is actually a synonymy of *L. confusa* (<http://flora.huh.harvard.edu/china/mss/volume19/Flora_of_China_Volume_19_Caprifoliaceae.pdf>, <http://www.theplantlist.org/tpl1.1/record/kew-2339927>). Hence, a complete review on similarities and differences of JYH and SYH is timely. In this review, we introduce botanies and ethnopharmacology of JYH and SYH, and discuss their similarities and differences with respect of phytochemistry, pharmacological activities and toxicology by systematically reviewing studies performed on JYH and SYH in recent decades. A critical evaluation of pharmacological studies in terms of their relation to ethnopharmacology is also provided. We generalize factors that affect their qualities and present quality control methods. Meanwhile, bioavailability of major compounds and clinical uses of JYH productions have also been mentioned. Above all, we provide an accurate cognition of JYH and SYH, and propose deficiencies on present studies so as to further research can use for reference.

Botany and ethnopharmacology {#Sec2}
============================

Botany {#Sec3}
------

The order Dipsacales comprises a monophyletic taxon with two major lineages, namely Caprifoliaceae (including Valerianaceae, Dipsacaceae, Diervilleae, Caprifolieae, Linnaeeae and Morinaceae) and Adoxaceae (Fan et al. [@CR39]; Group et al. [@CR50]). In addition, Caprifolieae clade contains *Leycesteria* (6 species), *Lonicera* (about 200 species), *Symphoricarpos* (about 15 species) and *Triosteum* (6 species) (Theis et al. [@CR177]), among which the genera *Lonicera* and *Triosteum* have a very close relationship (Fan et al. [@CR39]). There are two subgenera in *Lonicera*, namely *Chamaecerasus* (or *Lonicera*) and *Periclymenum* (or *Caprifolium*) with approximately 150 and 20 species, respectively (Rehder [@CR148]).

JYH {#Sec4}
---

According to eFloras ([http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=118877](http://www.efloras.org/florataxon.aspx%3fflora_id%3d2%26taxon_id%3d118877)) and 2015 Edition ChP, *L. japonica* is semi-evergreen climber. Branches, petioles, and peduncles with dense and yellow--brown spreading stiff hairs intersperse with long glandular hairs. Petioles are 3--8 mm. Leaves blades are ovate or oblong to lanceolate and they abaxially are sparsely to densely hairy, adaxially hairy along veins. Flowers are fragrant, paired and axillary toward apices of branchlets. Peduncles are 2--40 mm. Bracts are leaflike, ovate to elliptic. Bracteoles are pubescent, apex round or truncate and ciliate. Calyx lobes are triangular and densely hairy abaxially. Bilabiate corollas are hairy spreading with interspersing long glandular hairs outside. JYH is rod-shaped, slightly curved and 2--3 cm long, upper diameter about 3 mm, lower diameter about 1.5 mm. JYH is yellow--white or green--white, densely pubescent. The flowering phase ranges from May to September, and could be divided into six stages, the juvenile bud stage, the third green stage, the second white stage, the complete white stage, the silver flowering stage and the gold flowering stage (S1-S6) (Wang et al. [@CR192]).

*L. japonica* usually grows in scrub, sparse forests, mountain slopes, stony places or roadsides at an altitude of 800--1500 m ([http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=118877](http://www.efloras.org/florataxon.aspx%3fflora_id%3d2%26taxon_id%3d118877)). As an ornamental and economic plant, *L. japonica* is cultivated or naturally distributed in most provinces of China (Li et al. [@CR113]; Wang et al. [@CR189]). Henan and Shandong provinces are considered as its main genuine producing areas (Shang et al. [@CR157]). Miyinhua (production name, from Henan province), the geo-authentic crude drug (GCD) is famous for its long cultivation history and remarkable efficacy. The amount of Jiyinhua (production name, GCD from Shandong province) accounts for 35% of the total amount of JYH in China (<http://www.jyhzj.com/>).

SYH {#Sec5}
---

SYH is semi-evergreen climbers with fragrant and paired flowers. Botanical traits of inflorescences and bracts are strategic points to differentiate four origins of SYH (Table [1](#Tab1){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}). Its flowering phase is April to September. Table 1Botanical traits comparison of four origins of SYH (<http://www.efloras.org/>)Botanical traits*L. macranthoides (L. macrantha)L. hypoglaucaL. confusa* (*L. dasystyla*)*L*. *fulvotomentosa (L. macrantha)*Color and glandular hairsYellow or yellow--greenYellow--white to yellow--brown, glabrous or sparseGray--brown to yellow--brown, densely gray--white hairsPale yellow--brown or yellow--brown, densely yellow hairsFlower branchesConical-like inflorescences of paired flowers, densely in axilsShort raceme inflorescences, single-paired flowers in axilsShort raceme inflorescences, single-paired flowers in axilsShort raceme inflorescences, single-paired flowers in axilsBractsLanceolateLanceolateLanceolateFilateTexture of leavesLeatheryPaperyPaperyPaperyLeavesOrange--yellow glandular hairsAbaxially large sessile orange glandular hairsDense glandular hairsDensely filemot glandular hairsMedicinal partRod-shaped, slightly curved, 3--4.5 cm long, upper diameter about 2 mm, lower 1 mm2.5--4.5 cm long, diameter 0.5--2 mm1.6--3.5 cm long, diameter 0.5--2 mm1--3.4 cm long, diameter 1.5--2 mmFig. 1**a***L. japonica*, **b***L. macranthoides,***c***L. hypoglauca*, **d***L. confusa*, **e***L*. *fulvotomentosa* ([www.sfda.gov.cn/](http://www.sfda.gov.cn/))

Four origins of SYH are widely cultivated in southern provinces of China. Wild plants grow in forests of mountain valleys or slopes, scrub, riversides, streamside or roadsides at an altitude of 200--2900 m (<http://www.efloras.org/>). Among them, *L. macranthoides* is the most cultivated one and dominates the current market, even popular than JYH. *L. confusa* is cultivated rarely and barely used (Chen et al. [@CR24]).

On the basis of '*Ben Cao Gang Mu*' and '*Zhi Wu Ming Shi Tu Kao*' (AD 1841--1846), the plant origin of JYH was typical climber with paired and opposite flowers axillary toward apices of branchlets. Ovate leaves were adaxially hairy along veins. Only *L. japonica* complies with the ancient records of JYH, whereas four origins of SYH are markedly different.

In sharp contrast with explicitly mono origin of JYH, a gap exists in the synonyms confusion of SYH origins. *L. dasystyla* is a synonym of *L. confusa* ([www.theplantlist.org/](http://www.theplantlist.org/), <http://www.efloras.org/>). However, they are regarded as different herbs by not a few researchers nowadays (Ou et al. [@CR134]; Lim [@CR116]). This is possibly due to they were once listed as two herbs in ChP for quite a long time. Moreover, *L. macranthoides* and *L. fulvotomentosa* were listed as two different plants in 2010 and 2015 Edition ChP, while they were synonyms of *L. macrantha* according to The Plant List and eFloras ([www.theplantlist.org/](http://www.theplantlist.org/), <http://www.efloras.org/>). As far as current research is concerned, it is difficult to point out their similarities or differences. Thereby studies on genetic diversity and relationships should be conducted. An evaluation of pharmacological studies of them should also be high-lighted.

Ethnopharmacology {#Sec6}
-----------------

*Lonicerae japonica* was first recorded in '*Shen Nong Ben Cao Jing*' in the Eastern Han Dynasty (AD 25--220) and stems were used medicinally at that time. In '*Ben Cao Shi Yi*' (the Tang Dynasty, AD 618--709), stems of *L. japonica* were used to treat bloody dysentery. In '*Su Shen Liang Fang*' (the Northern Song Dynasty, AD 960--1127), stems were considered as anti-inflammatory agents. Based on '*Dian Nan Ben Cao*' (the Ming Dynasty, AD 1368--1644), the main function of stems was to cure ulcer and sore. In '*Ben Cao Gang Mu*' (the Ming Dynasty, written later than '*Dian Nan Ben Cao*'), flowers were used as medicine for the first time. Besides, flowers, stems and leaves of *L. japonica* had the same efficacy when it comes to treatment of swelling and scabies (Table [2](#Tab2){ref-type="table"}).Table 2Traditional uses of *L. japonica*No.Prescription nameMain herbs/used partTraditional useAdministration and application areaReference1Yinju Baihu DecoctionJYH, dried capitulum of *Chrysanthemum indicum* Linnaeus, GypsumClearing heat and toxic, and expelling superficial evilsOral'Qianjin Miaofang'2Yinqiao PowderJYH, dry fruits of *F. suspensa*Curing headache, fever and coughOral'Wenbing Tiaobian'3Yinhua DecoctionJYH, dried roots of *Astragalus membranaceus* (Fisch.) Bunge or *A. membranaceus* (Fisch.) Bunge var. *mongholicus* (Bunge) HsiaoCuring phyma and relieving painOral'Zhulin Nvke Zhengzhi'4Jinyin PowderJYHCuring carbuncle and soreExternal use'Yangshi Jiachang Fang'5Jinyin Jiedu DecoctionJYH, dried bulbs of *Fritillaria thunbergii* MiquelCuring acne and scabPoulticeExternal use'Youke Zhiyan'6Simiao Yongan DecoctionDried roots of *Scrophularia ningpoensis* Hemsley, JYHPromoting blood circulation and relieving painOral'Yanfang Xinbian'7Liuwu Jiedu DecoctionDried roots of *Smilax glabra* Roxburgh, JYH, dried roots of *Ligusticum chuanxiong* hortulanorumCuring sore, distending painOral'Meili Xinshu'8Wushen DecoctionDried sclerotia of *Poria cocos* Wolf, dried ripe fruits of *Plantago asiatica* Linnaeus or *Plantago depressa* Willdenow, JYHCuring carbuncleOral'Bianzheng Lu'9Xiaohua DecoctionJYH, Begonia fimbristipula, dried roots of *Trichosanthes kirilowii* Maximowicz or *Trichosanthes rosthornii* HarmsClearing heat and toxic, promoting blood circulation and eliminating phlegmOral'Waike Milu'

Nowadays, flowers as well as other parts, particularly stems and leaves, of the five *Lonicera* species are applied to clean heat and toxic, expel wind and cool blood in traditional Chinese medicine, while JYH and SYH actually concern dried flower buds or initial flowers only. According to 2015 Edition ChP, stems of *L. japonica* are used medicinally, called Lonicera Japonica Caulis. Yet leaves, non-medicinal part of *L. japonica*, have not been fully utilized. Modern studies have confirmed that flowers, stems and leaves of *L. japonica* have similar chemical compounds with a variety of pharmacological activities. Flavonoids in *L. japonica* were degressively abundant in leaves, flowers and stems, and leaves showed the highest antioxidative intensity than those of flowers or stems (Seo et al. [@CR154]). Tian found that phenolic acids in flowers and leaves were similar and both were higher than that in stems (Tian et al. [@CR180]), and these results could also be found in SYH (Chen et al. [@CR25]; Yuan et al. [@CR230]). Meanwhile, powder of SYH leaves has already been used as dietary supplementation in animal diets (Long et al. [@CR122]). In China, JYH has been used as tea for a long time. The sales of Wanglaoji (trade name), a tea beverage containing JYH, exceeded that of Coca-Cola in 2018. The supply of JYH is not adequate to the demand (<http://www.sohu.com>), while leaves of *L. japonica* are wasted greatly despite having a long history as tea (Wang et al. [@CR189]). Leaves of *L. japonica* have been considered as medicinal part in Japan and Korea according to the Japanese Pharmacopoeia and the Korean Pharmacopoeia. Therefore, in China, leaves of *L. japonica* and SYH origins should be valued in further studies.

JYH is typically matched with *Forsythia suspensa* (Thunberg) Vahl (Oleaceae) to clear heat and toxic, thereby curing seasonal febrile disease and sore. Another combination of JYH and *Scutellaria baicalensis* Georgi (Lamiaceae) is commonly used for the treatment of cough caused by lung fire. Shuang--Huang--Lian (SHL), a combination of JYH, *F. suspensa* and *S. baicalensis*, is the most typical formula to explain the traditional use of JYH. As a classic formula, SHL has been used for the treatment of cough, sore throat and fever, acting by dispelling wind, clearing heat and detoxification (Han et al. [@CR57]; Tang et al. [@CR175]; Tian et al. [@CR179]). Till now, SHL has also been used extensively, and its preparations involve granules, oral liquid, injection, etc.

According to 2015 Edition ChP, JYH is developed into 87 CPMs in dosage form of pill, granules and liquid pharmaceutical preparations for oral consumption and multiple external preparations such as suppositories, eye drops, electuary, injection, etc. Additionally, 14 CPMs containing SYH are recorded, which are in dosage form of 13 oral preparations and1 external spraying agent (Table [3](#Tab3){ref-type="table"}).Table 3Preparations of JYH and SYH listed in 2015 Edition ChPNameTypeMain herbsFunction*JYH*YinhuangOral liquidJYH, Scutellariae RadixCuring acute and chronic tonsillitis and upper respiratory tract infectionJinyinhuaDistilled liquidJYHClearing heat and toxic. Curing pimples and sore throatXiaoer YanbianGranuleJYH, Belamcandae RhizomaCuring sore throat, cough and phlegmJingqi JiangtangTabletCoptidis Rhizoma, Astragali Radix, JYHCuring light and moderate Type 2 diabetesNiuhuang JingnaoTabletBovis Calculus Artifactus, JYHCuring mania and dizziness caused by excessive heatLianhua QingwenGranuleForsythiae Fructus, JYHCuring influenzaShuanghu QingganGranuleJYH, Polygoni Cuspidati Rhizoma et RadixCuring nausea, anorexia and chronic hepatitis BShuanghuanglianSuppositoryJYH, Forsythiae Fructus, Scutellariae RadixCuring cold caused by exogenous wind and heat*SYH*FengreqingOral liquidSYH, Bear bile powderCuring colds, headache, cough, thirstFufang Zhenzhu AnchuangTabletSYH, Taraxaci herbaCuring acneYinqiao ShangfengCapsuleSYH, Forsythiae FructusCuring exogenous wind-heat, febrile disease at the beginningYinpujieduTabletSYH, TaraxaciherbaCuring wind-heat acute pharyngitis and damp-heat pyelonephritisQinggan LidanOral liquidArtemisiae Scopariae Herba, SYHCuring dumbness and hypochondriac pain induced by damp-heat congestion of liver and gallbladder

In brief, JYH recorded in ancient books should be *L. japonica* rather than any four origins of SYH according to the classical Chinese medical treatises. Genetic diversity and pharmacological studies of *L. macranthoides* and *L. fulvotomentosa* should be high-lighted. *L. japonica* has been successfully used medicinally in China for over 2000 years. Nowadays stems and flowers of *L. japonica* are traditionally and ethnobotanically used to cure sore, carbuncle, scab, erysipelas, distending pain, etc., generally, while leaves have similar efficacy with flowers based on the reported literature but are not utilized well, which need to be further investigated for solving the ongoing short supply of JYH.

Phytochemistry {#Sec7}
==============

Previous phytochemical studies have indicated JYH and SYH multiplicate composition, predominantly phenolic acids, flavonoids, iridoids and saponins. Both of the two herbs contain a lot of essential oils. To date, a total of 326 compounds and 148 compounds have been isolated and identified from JYH and SYH (Yang et al. [@CR218]; Ni [@CR132]; Lin et al. [@CR117]; Wu et al. [@CR207]). Compounds presenting in JYH and SYH are summarized in Table [4](#Tab4){ref-type="table"}, and the major ones are illustrated in Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}. Moreover, the differences on contents of major compounds are exhibited in Table [5](#Tab5){ref-type="table"}. To expound advances in pharmacological study, the bioactive compounds of JYH and SYH are reviewed in Table [6](#Tab6){ref-type="table"}.Table 4Compounds presenting in JYH and/or SYHNo.CompoundJYHReferenceSYHOriginsReferencesPubChem CIDPartsExtractionPartsExtraction**Phenolic acids***Chlorogenic acids derivatives common for JYH and SYH*1Chlorogenic acidWhole plantDistilled waterPeng et al. ([@CR141])Flower budsn-Butyl alcohol1, 2, 3, 4Yang et al. ([@CR218])17944272Neochlorogenic acidFlower buds95% ethanolJin-qian et al. ([@CR80])Flowers/flower budsDistilled water1Yang et al. ([@CR218])52806333Isochlorogenic acid AUnknownUnknownChang and Hsu ([@CR11])Flowers/flower budsDistilled water1, 2, 3, 4Yao et al. ([@CR221]), Dan et al. ([@CR34])64743104Isochlorogenic acid BUnknownUnknownChang and Hsu ([@CR11])Flowers/flower budsDistilled water1, 2, 3, 4Yao et al. ([@CR221]), Dan et al. ([@CR34])52817805Isochlorogenic acid CUnknownUnknownChang and Hsu ([@CR11])Flowers/flower budsDistilled water1Yao et al. ([@CR221])64743096Cryptochlorogenic acidFlower buds95% ethanolJin-qian et al. ([@CR80])Flowers/Flower budsDistilled water1Yao et al. ([@CR221])9798)6667CynarinUnknownUnknownIwahashi et al. ([@CR69])Flower budsDistilled water1Zhang et al. ([@CR235])52817698Methyl chlorogenateFlower budsEthanolLee et al. ([@CR100])Flower budsn-Butyl alcohol4Chai et al. ([@CR8])6476139*Chlorogenic acids derivatives only for JYH*91,5-*O*-Dicaffeoylquinic acidLeavesDistilled waterChan-juan and Si-ping ([@CR13])122685101,4-*O*-Dicaffeoylquinic acidLeavesDistilled waterChan-juan and Si-ping ([@CR13])12358846115-p-Coumarylquinic acidLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])644128012Feruloylcaffeoylquinic acidLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])13Chlorogenic acid butyl esterUnknownUnknownWang ([@CR186])14Methyl 3,5-di-*O*-caffeoylquinic acidWhole plantUnknownChang et al. ([@CR12])15Methyl 3,4-di-*O*-caffeoylquinic acidWhole plantUnknownChang et al. ([@CR12])5319160163-*O*-Caffeoylquinic acid ethyl esterFlower budsEthanolLee et al. ([@CR100])175-*O*-Caffeoylquinic acid butyl esterFlower budsEthanolLee et al. ([@CR100])185-*O*-Caffeoylquinic acid methyl esterFlower budsEthanolLee et al. ([@CR100])54585255193,5-*O*-Dicaffeoylquinic acid methyl esterFlower budsUnknownPeng et al. ([@CR141])203,5-*O*-Dicaffeoylquinic acid butyl esterFlower budsUnknownPeng et al. ([@CR141])213,5-*O*-Dicaffeoylquinic acid ethyl esterFlower budsBoiling waterZheng et al. ([@CR239])223,4-*O*-Dicaffeoylquinic acid methyl esterFlower budsBoiling waterZheng et al. ([@CR239])233,4-*O*-Dicaffeoylquinic acid ethyl esterFlower budsBoiling waterZheng et al. ([@CR239])244,5-*O*-Dicaffeoylquinic acid methyl esterFlower budsBoiling waterZheng et al. ([@CR239])25(−)-4-*O*-(4-*O*-β-[d]{.smallcaps}-glucopyranosylcaffeoyl) quinic acidFlower budsUnknownYu et al. ([@CR228])26(−)-3-*O*-(4-*O*-β-[d]{.smallcaps}-glucopyranosylcaffeoyl) quinic acidFlower budsUnknownYu et al. ([@CR228])27(−)-5-*O*-(4-*O*-β-[d]{.smallcaps}-glucopyranosylcaffeoyl) quinic acidFlower budsUnknownYu et al. ([@CR228])*Chlorogenic acids derivatives only for SYH*285-*O*-Caffeoyl quinic acid butyl esterFlower budsn-butyl alcohol4Chai et al. ([@CR8])6481825293,4-Dicaffeoylquinic acid methyl esterFlower budsEthyl acetate2Tang et al. ([@CR173])304,5-Dicaffeoylquinic acid methyl esterFlower budsEthyl acetate2Tang et al. ([@CR173])31Ethyl-3-*O*-caffeoylquinateFlower budsn-butanol1Hu et al. ([@CR63])32Butyl 5-caffeoyl quinineUnknownUnknownUnknownChai et al. ([@CR8])333,4,5-tri-*O*-Caffeoylquinic acidFlower budsn-butanol1Hu et al. ([@CR63])644078334Ethyl-4,5-di-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])35Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])25243950362-Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])373-Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])10131826384-Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])49821869395-Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])5281762406-Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])413,4,5-tri-*O*-Caffeoylshikimic acidFlower budsDistilled water1Zhang et al. ([@CR235])423-*O*-p-Coumaroylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])9945785434-*O*-p-Coumaroylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])10163942244Ethyl-3,5-di-*O*-CaffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])45p-Coumaroyl-caffeoylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])46Methyl 3-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])47Methyl 1-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])48Methyl 4-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])493-Feruloyl-4-caffeoylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])91617958503-Caffeoyl-4-feruloylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])131752147513-Feruloyl-5-caffeoylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])101710864523-Caffeoyl-5-feruloylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])101710863534-Feruloyl-5-caffeoylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])9936820544-Caffeoyl-5-feruloylquinic acidFlower budsDistilled water1Zhang et al. ([@CR235])9213580155Methyl 1,3-di-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])56Methyl-3,4-di-*O*-caffeoylquinateFlower budsDistilled water1, 2Zhang et al. ([@CR235]), Guan et al. ([@CR51])13175214857Methyl-3,5-di-*O*-caffeoylquinateFlower budsDistilled water1, 2Zhang et al. ([@CR235]), Guan et al. ([@CR51])1007568158Methyl-1,4-di-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])59Methyl-4,5-di-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])60Methyl-1,5-di-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])61Ethyl-3,4-di-*O*-caffeoylquinateFlower budsDistilled water1Zhang et al. ([@CR235])10554540*Cinnamic acids derivatives common for JYH and SYH*62Caffeic acidFlowersMethanolChoi et al. ([@CR28])Flower budsEthyl acetate4Chai et al. ([@CR8])689043633-*O*-Feruloylquinic acidLeaves/Flowers/Stems70% methanolIwahashi et al. ([@CR69])Flower budsDistilled water1Zhang et al. ([@CR235])10133609644-*O*-Feruloylquinic acidFlowers/Flower budsEthanolInstitute ([@CR68])Flower budsDistilled water1Zhang et al. ([@CR235])4635494655-*O*-Feruloylquinic acidUnknownUnknownIwahashi et al. ([@CR69])Flower budsDistilled water1Zhang et al. ([@CR235])9799386661-*O*-Caffeoylquinic acidUnknownUnknownChang and Hsu ([@CR11])Flower budsn-butyl alcohol1Xu et al. ([@CR213])13175106667Trans-Cinnamic acidFlowers/Flower budsEthyl acetateWang et al. ([@CR196])Flowers/Flower budsEthyl acetate4Wen et al. ([@CR202])44453968Trans-Ferulic acidWhole plant95% ethanolJeong et al. ([@CR71])Flowers/Flower budsEthyl acetate3Yao et al. ([@CR222])445858*Cinnamic acids derivatives only for JYH*69Caffeic acid methyl esterUnknownUnknownChang and Hsu ([@CR11])68907570Methyl 4-caffeoylquinateFlowers/Flower budsDistilled waterYu et al. ([@CR229])7172084071Ethyl cinnamateFlower buds95% ethanolJiang ([@CR76])63775872CaffeoylglycerolLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])12972805073Methyl 4-*O*-β-[d]{.smallcaps}-glucopyranosyl caffeateFlowers/Flower budsDistilled waterYu et al. ([@CR229])74Caffeic acid ethyl esterFlower buds95% ethanolJiang ([@CR76])5317238754-Hydroxycinnamic acidFlower buds/LeavesAcetoneFeng et al. ([@CR44]), Wang ([@CR187])63754276Methyl 4-hydroxycinnamateFlower budsAcetoneFeng et al. ([@CR44])531956277Isoferulic acidLeavesEthanolWang ([@CR187])736186783-(3,4-Dihydroxyphenyl) propionic acidFlower budsAcetoneFeng et al. ([@CR44])348154*Cinnamic acids derivatives only for SYH*791-*O*-DimethoxycinnamoylquinicFlower budsDistilled water1Zhang et al. ([@CR235])803-*O*-DimethoxycinnamoylquinicFlower budsDistilled water1Zhang et al. ([@CR235])814-*O*-DimethoxycinnamoylquinicFlower budsDistilled water1Zhang et al. ([@CR235])*Benzoic acids derivatives common for JYH and SYH*822,5-Dihydroxybenzoic acid-5-*O*-β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])Flowers/Flower budsEthyl acetate4Wen et al. ([@CR202])*Benzoic acids derivatives only for JYH*83Vanillic acidFlower budsEthanolLee et al. ([@CR100])846884Vanillic acid 4-*O*-β-[d]{.smallcaps}-(6-*O*-benzoyl glucopyranoside)Flower budsEthanolLee et al. ([@CR100])85Vanillic acid-4-*O*-β-[d]{.smallcaps}-(6-*O*-benzoyl pyranoside)Flower budsEthanolLee et al. ([@CR100])86Protocatechuic acidFlowersMethanolChoi et al. ([@CR28])528594874-Hydroxybenzoic acidFlower budsEthanolLi and Li ([@CR108])135**Flavonoids***Flavones common for JYH and SYH*88CynarosideFlower budsEthyl acetateShuang-Cheng ([@CR163])Flower budsMethanol1, 2, 3, 4Zhang et al. ([@CR234])4425820589LuteolinFlowersMethanolChoi et al. ([@CR28])Flower budsEthyl acetate4Chai et al. ([@CR7])528044590Chrysoeriol 7-*O*-neohesperidosideFlowersMethanolChoi et al. ([@CR28])Flower budsn-butyl alcohol4Chai et al. ([@CR7])4459348691Chrysoeriol 7-*O*-glucosideFlowersMethanolChoi et al. ([@CR28])Flower budsEthyl acetate1Jia et al. ([@CR75])1129417792LonicerinWhole plantn-butanolLee et al. ([@CR98])Flower budsPetroleum ether1, 3, 4Chai et al. ([@CR9]), Chen et al. ([@CR16])528215293TricinFlower budsn-butyl alcoholChai et al. ([@CR7])Flower budsn-butyl alcohol4Chai et al. ([@CR7])528170294Tricin 7-*O*-glucosideFlower budsUnknownRen et al. ([@CR149])Flower budsn-butyl alcohol4Chai et al. ([@CR7])4425826795Tricin 7-*O*-neohesperidosideFlower budsn-butyl alcoholHuang et al. ([@CR65])Flower budsn-butyl alcohol4Chai et al. ([@CR7])44258269*Flavones only for JYH*96ChrysoeriolDried flowersMethanolChoi et al. ([@CR28])528066697RhoifolinAerial partsMethanolSon et al. ([@CR164])528215098Flavoyadorinin BFlower budsEthanolLee et al. ([@CR100])1437637699CupressuflavoneUnknownUnknownChoi et al. ([@CR28])5281609100DiosmetinUnknownUnknownChoi et al. ([@CR28])52816121015,3′-DimethoxyluteolinFlower budsAcetoneFeng et al. ([@CR44])1025-Hydroxy-7,4′-dimethoxyflavoneFlower budsPetroleum etherXing et al. ([@CR210])103Luteolin 7-*O*-β-[d]{.smallcaps}-galactosideFlowersMethanolChoi et al. ([@CR28])5488493104Luteolin 3′-rhamnosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])44258072)105ChrysinLeaves80% methanolKumar et al. ([@CR91])5281607106Diosmetin 7-*O*-β-[d]{.smallcaps}-glucosideLeavesEthanolWang ([@CR187])11016019107ApigeninAerial partsEthyl acetateZhang et al. ([@CR232])5280443108Apigenin-7-*O*-α-[l]{.smallcaps}-rhamnopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])109CorymbosinFlowers/Flower budsAlcoholHuang et al. ([@CR64])109703761105-Hydroxy-3′,4′,7-TrimethoxylflavoneFlowers/Flower budsAlcoholHuang et al. ([@CR64])5272653111OchnaflavoneAerial partsEthyl acetateSon et al. ([@CR164])5492110112Ochnaflavone 4′-*O*-methyletherAerial partsEthyl acetateSon et al. ([@CR164])1135,3′-Dimethoxy luteolinFlower buds50% aqueous acetoneFeng et al. ([@CR44])114Luteolin-5-*O*-β-[d]{.smallcaps}-glucopyranosideFlower buds50% aqueous acetoneFeng et al. ([@CR44])53174711155-Hydroxy-6,7,8,4′-tetramethoxy flavoneFlower buds95% ethanolJiang ([@CR76])1165-Hydroxy-7,4′-dimethoxyflavoneFlower budsEthyl acetateXing et al. ([@CR210])1175-Hydroxy-7,3′,4′,5′-tetramethoxyflavoneFlower budsEthyl acetateXing et al. ([@CR210])1185,7,3′,4′,5′-pentamethoxyflavoneFlowers/Flower budsEthyl acetateCui et al. ([@CR31])4933761195,4′-Dihydroxy3′,5′-dimethoxy-7-*O*-β-[d]{.smallcaps}-glucoxy flavoneFlowers/Flower buds30% ethanolZhen ([@CR238])120Luteolin *O*-dihexosideLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])121Apigenin 7-*O*-hexosideLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])122Apigenin 7-*O*-rutinosideLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])5377847123TrihydroxymethoxyflavoneLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])*Flavone only for SYH*124Chrysoeriol-7-*O*-xylosideFlower budsn-butanol1Hu et al. ([@CR63])*Flavonols common for JYH and SYH*125RutinUnknownUnknownChang and Hsu ([@CR11])Flower budsn-butanol1, 4Chen et al. ([@CR15]), Chai et al. ([@CR8])5280805126QuercetinAerial partsMethanolSon et al. ([@CR164])Flower budsEthyl acetate3, 4Chai et al. ([@CR9]), Chai et al. ([@CR7])5280343127AstragalinAerial partsMethanolSon et al. ([@CR164])UnknownUnknownUnknownChen et al. ([@CR15])5282102128IsoquercitrinAerial partsMethanolSon et al. ([@CR164])Flower budsEthyl acetate1Jia et al. ([@CR75])5280804129Isorhamnetin 3-*O*-glucosideFlowersMethanolChoi et al. ([@CR28])Flower budsn-butyl alcohol1Chen et al. ([@CR17])5318645130HyperosideFlower budsEthyl acetateNi ([@CR132])Flower budsMethanol1, 3, 4Huang et al. ([@CR65])5281643*Flavonols only for JYH*1313-MethoxyluteolinFlower budsAcetoneFeng et al. ([@CR44])132Isorhamnetin 3-*O*-rutinosideFlowersUnknownWang ([@CR186])5481663133Kaempferol 3-*O*-β-[d]{.smallcaps}-rutinosideFlower budsUnknownWang ([@CR186])5318767134Kaempferol 3-*O*-hexosideFlower budsEthyl acetateNi ([@CR132])135Quercetin-7-*O*-β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsn-butyl alcoholChen et al. ([@CR20])5282160136Quercetin 3-*O*-hexosideLeaves/Flowers/Stems70% methanolSeo et al. ([@CR154])5378597*Flavonol only for SYH*137KaempferolFlowers/Flower budsEthyl acetate3Yao et al. ([@CR222])5280863*Flavonolignan only for JYH*138HydnocarpinAerial partsMethanolSon et al. ([@CR164])5489114*Flavanone only for JYH*139EriodictyolAerial partsEthyl acetateZhang et al. ([@CR232])440735*Biflavonoids only for JYH*1403′-*O*-Methyl loniflavone\[5,5″,7,7″-tetrahydroxy 3′-methoxy 4′,4‴-biflavonyl etherLeaves80% methanolKumar et al. ([@CR91])141Loniflavone \[5,5″,7,7″,3′-pentahydroxy 4′,4‴-biflavonyl etherLeaves80% methanolKumar et al. ([@CR91])**Iridoids**142LoganinFlowersButanolTomassini et al. ([@CR182])Flowers/Flower budsEthyl acetate3Yao et al. ([@CR222])87691143SwerosideFlowersButanolTomassini et al. ([@CR182])Flowers/Flower buds50% methanol1, 2, 3, 4Chen et al. ([@CR16]), Zhang et al. ([@CR234])161036144SecologanosideFlower budsDistilled waterSong ([@CR165])Flower buds30% ethanol1Chen et al. ([@CR22])14136853145Ethyl secologanosideFlower buds75% ethanolLiu et al. ([@CR120])Flower budsMethanol1Liu et al. ([@CR118])146CentaurosideLeaves/Flowers buds/Stems70% ethanolLee et al. ([@CR101]), Machida et al. ([@CR127])Flower buds50% methanol3Chen et al. ([@CR16])64406981477-EpiloganinFlower budsEthanolLi and Li ([@CR108])Flower budsEthyl acetate3Li et al. ([@CR110])443343148SecoxyloganinFlower budsEthyl acetateMa et al. ([@CR125])Flower budsEthyl acetate1, 3, 4Chen et al. ([@CR16]), Lee ([@CR97])162868149Secologanic acidFlower budsEthyl acetateNi ([@CR132])5321213150SecologaninFlowersButanolTomassini et al. ([@CR182])1612761517-Epi vogelosideFlowers/Flower budsChloroformBi et al. ([@CR5])152MorronisideFlower budsUnknownKakuda et al. ([@CR83])11304302153Loganin aglyconeRoots95% ethanolJin-qian et al. ([@CR80])1547-Dimethyl-secologanosideLeavesEthanolWang ([@CR187])155Secologanin dimethyl acetalLeaves/Flower budsEthyl acetateMachida and Asano ([@CR126]), Lee et al. ([@CR101])1571401567-*O*-Butylsecologanic acidFlowersButanolTomassini et al. ([@CR182])101687692157Secologanin dibutylacetalFlowersButanolTomassini et al. ([@CR182])158KingisideFlower budsUnknownKakuda et al. ([@CR83])12304884159VogelosideFlower budsn-butyl alcoholSong et al. ([@CR167])14192588160Epi-vogelosideFlower budsn-butyl alcoholSong et al. ([@CR167])14192590161KetologaninFlower budsDistilled waterSong ([@CR165])1627α-MorronisideFlower budsDistilled waterSong ([@CR165])1637β-MorronisideFlower budsDistilled waterSong ([@CR165])164Lonijaposide AFlower budsDistilled waterLiu et al. ([@CR120])24879108165Lonijaposide A1FlowersMethanolKumar et al. ([@CR92])166Lonijaposide A2FlowersMethanolKumar et al. ([@CR92])167Lonijaposide A3FlowersMethanolKumar et al. ([@CR92])168Lonijaposide A4FlowersMethanolKumar et al. ([@CR92])169Lonijaposide BFlower budsDistilled waterLiu et al. ([@CR120])24879110170Lonijaposide B1FlowersMethanolKumar et al. ([@CR92])171Lonijaposide B2FlowersMethanolKumar et al. ([@CR92])172Lonijaposide CFlower budsDistilled waterLiu et al. ([@CR120])24879106173Lonijaposide DFlower budsDistilled waterSong ([@CR165])56599664174Lonijaposide EFlower budsDistilled waterSong ([@CR165])56599666175Lonijaposide FFlower budsDistilled waterSong ([@CR165])56599668176Lonijaposide GFlower budsDistilled waterSong ([@CR165])56599669177Lonijaposide HFlower budsDistilled waterSong ([@CR165])56599868178Lonijaposide IFlower budsDistilled waterSong ([@CR165])56598336179Lonijaposide JFlower budsDistilled waterSong ([@CR165])56599869180Lonijaposide KFlower budsDistilled waterSong ([@CR165])56599871181Lonijaposide LFlower budsDistilled waterSong ([@CR165])56599872182[l]{.smallcaps}-PhenylalaninosecologaninStems/leavesMethanolMachida et al. ([@CR127])1011891421837-*O*-(4-β-[d]{.smallcaps}-Glucopyranosyloxy-3-methoxy-benzoyl) secologanolic acidStems/leavesMethanolMachida et al. ([@CR127])1846′-*O*-(7α-Hydroxyswerosyloxy) loganinStems/leavesMethanolMachida et al. ([@CR127])185(E)-AldosecologaninStems/leavesMethanolMachida et al. ([@CR127])45783101186Loniceracetalide AFlower budsEthyl acetateKakuda et al. ([@CR83])187Loniceracetalide BFlower budsEthyl acetateKakuda et al. ([@CR83])1888-EpiloganinFlower budsBoiling waterLiu et al. ([@CR120])10548420189Loganic acidFlower budsBoiling waterLiu et al. ([@CR120])896401908-Epiloganic acidFlower budsBoiling waterLiu et al. ([@CR120])158144191Secologanoside-7-methyl esterFlower budsEthyl acetateKakuda et al. ([@CR83])140382971928-EpikingisideFlower budsBoiling waterLiu et al. ([@CR120])123048861937-Hydroxy-methyl-vogelosideUnknownUnknownTian ([@CR178])194LoniaceticiridosideFlower budsDistilled waterSong et al. ([@CR169])195LonimalondialiridosideFlower budsDistilled waterSong et al. ([@CR169])1966′-*O*-AcetylvogelosideFlowers/Flower buds95% ethanolXu et al. ([@CR214])1976′-*O*-AcetylsecoxyloganinFlowers/Flower buds95% ethanolXu et al. ([@CR214])198Adinoside AFlowers/Flower budsEthyl acetateWang et al. ([@CR196])11144737199StryspinosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])76331806200DimethylsecologanosideFlower budsEthyl acetateMa et al. ([@CR125])14105070201Loniphenyruviridoside AUnknownUnknownYu et al. ([@CR225])57395335202Loniphenyruviridoside BUnknownUnknownYu et al. ([@CR225])56598467203Loniphenyruviridoside CUnknownUnknownYu et al. ([@CR225])57398873204Loniphenyruviridoside DUnknownUnknownYu et al. ([@CR225])56598469205Loniceranan ADried flower buds75% ethanolLiu et al. ([@CR120])206Loniceranan BDried flower buds75% ethanolLiu et al. ([@CR120])207Loniceranan CDried flower buds75% ethanolLiu et al. ([@CR120])208DemethylsecologanolDried flower buds75% ethanolLiu et al. ([@CR120])209HarpagideDried flower buds75% ethanolLiu et al. ([@CR120])10044294210HarpagosideDried flower buds75% ethanolLiu et al. ([@CR120])52815422116″-*O*-β-GlucopyranosylharpagosideDried flower buds75% ethanolLiu et al. ([@CR120])212(7β)-7-*O*-Methyl morronisideDried flower buds75% ethanolLiu et al. ([@CR120])213SerinosecologaninFlower budsDistilled waterSong et al. ([@CR168])214ThreoninosecologaninFlower budsDistilled waterSong et al. ([@CR168])215Lonijapospiroside AFlower buds70% ethanolZheng et al. ([@CR239])216[l]{.smallcaps}-Phenylalaninosecologanin BFlower buds70% ethanolZheng et al. ([@CR239])217[l]{.smallcaps}-Phenylalaninosecologanin CFlower buds70% ethanolZheng et al. ([@CR239])218Dehydroprolinoylloganin AFlower buds70% ethanolZheng et al. ([@CR239])219Lonijaposide MUnknownUnknownYu et al. ([@CR225])56599874220Lonijaposide NUnknownUnknownYu et al. ([@CR225])56600069221Lonijaposide OFlower budsDistilled waterYu et al. ([@CR227])222Lonijaposide PFlower budsDistilled waterYu et al. ([@CR227])223Lonijaposide QFlower budsDistilled waterYu et al. ([@CR227])224Lonijaposide RFlower budsDistilled waterYu et al. ([@CR227])225Lonijaposide SFlower budsDistilled waterYu et al. ([@CR227])226Lonijaposide TFlower budsDistilled waterYu et al. ([@CR227])227Lonijaposide UFlower budsDistilled waterYu et al. ([@CR227])228Lonijaposide VFlower budsDistilled waterYu et al. ([@CR227])229Lonijaposide WFlower budsDistilled waterYu et al. ([@CR227])2307-*O*-Ethyl swerosideFlower budsMethanolSong et al. ([@CR166])231Secoxyloganin 7-butyl esterFlower budsMethanolSong et al. ([@CR166])232GrandiflorosideRoots95% ethanolJin-qian et al. ([@CR80])200560122337-DehydrologaninFlower buds70% ethanolLee et al. ([@CR101])4433492346′-*O*-α-[l]{.smallcaps}-Arabinopyranosyl demethylsecologanolFlower budsMethanol1Liu et al. ([@CR118])**Saponins**235α-HederinFlower budsEthanolChen et al. ([@CR14])UnknownUnknownUnknownChen et al. ([@CR14])73296236Loniceroside AAerial partsMethanolHo Son et al. ([@CR60])Flowers/Flower budsEthyl acetateUnknownLin et al. ([@CR117])237Loniceroside BAerial partsMethanolHo Son et al. ([@CR60])Flowers/Flower budsEthyl acetateUnknownLin et al. ([@CR117])238Loniceroside CAerial partsButanolKwak et al. ([@CR93])Flowers/Flower budsEthyl acetateUnknownLin et al. ([@CR117])239Loniceroside DFlowers/Flower budsEthanolLin et al. ([@CR117])Flowers/Flower budsEthyl acetateUnknownLin et al. ([@CR117])240Loniceroside EFlowers/Flower budsEthanolLin et al. ([@CR117])Flowers/Flower budsEthyl acetateUnknownLin et al. ([@CR117])2413-*O*-α-[l]{.smallcaps}-Arabinopyranosyl-28-*O*-\[β-[d]{.smallcaps}-glucopyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl\] oleanolic acidAerial partsMethanolKawai et al. ([@CR87])Flower budsn-butyl alcohol1Chen et al. ([@CR15])2423-*O*-\[α-[l]{.smallcaps}-Rahmnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl\]-28-*O*-\[β-[d]{.smallcaps}-glucopyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl\] oleanolic acidAerial partsBoiling waterKawai et al. ([@CR87])Flower budsEthyl acetate1Jia et al. ([@CR74])243Hederagenin 3-*O*-α-[l]{.smallcaps}-arabinopyranosideFlowersEthyl acetateChoi et al. ([@CR28])244HederageninWhole plantButanolYu et al. ([@CR228])73299245Oleanolic acidFlower budsUnknownWang ([@CR186])10494246Ursolic acidFlowers/Flower buds95% ethanolXu et al. ([@CR214])64945247Nortirucallane AFlowers/Flower buds80% ethanolWang et al. ([@CR201])248Saponin 1Flower budsMethanolQi et al. ([@CR145])249Saponin 4Flower budsMethanolQi et al. ([@CR145])482163250DaucosterolFlowers/Flower budsEthyl acetateWang et al. ([@CR196])5742590251Oleanolic acid 28-α-*O*-l-rhamnopyranosyl-(1 → 2)-\[β-[d]{.smallcaps}-xylopyranosyl(1 → 6)\]-β-[d]{.smallcaps}-glucopyranosyol esterFlowersMethanolChoi et al. ([@CR28])252Hederagenin-3-*O*-α-[l]{.smallcaps}-rhamnopyranosyl1 → 2-α-[l]{.smallcaps}-arabinopyranosideFlower budsEthanolChen et al. ([@CR14])253Hederagenin-3-*O*-α-[l]{.smallcaps}-rhamnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosideFlower budsEthanolChen et al. ([@CR14])2543-*O*-\[α-[l]{.smallcaps}-Rahmnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl\]-28-*O*-β-[d]{.smallcaps}-glucopyranosyl hederageninAerial partsMethanolKawai et al. ([@CR87])2553-*O*-\[α-[l]{.smallcaps}-Rahmnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl\]-28-*O*-\[6-acetyl-β-[d]{.smallcaps}-glucopyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl\] hederageninAerial partsBoiling waterKawai et al. ([@CR87])2563-*O*-α-[l]{.smallcaps}-Arabinopyranosy hederagenin 28-*O*-α-[d]{.smallcaps}-rahmnopyranosyl(1 → 2)\[β-[d]{.smallcaps}-xylpyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower buds95% ethanolLou et al. ([@CR123])2573-*O*-α-[l]{.smallcaps}-Rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosy hederagenin 28-*O*-β-[d]{.smallcaps}-xylpyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower buds95% ethanolLou et al. ([@CR123])2583-*O*-α-[l]{.smallcaps}-Rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosy hederagenin 28-*O*-α-[d]{.smallcaps}-Rhamnopyranosyl(1 → 2)\[β-[d]{.smallcaps}-xylpyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosylesterFlower buds95% ethanolLou et al. ([@CR123])2593-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 4)-β-[l]{.smallcaps}-glucopyranosyl(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosy hederagenin28-*O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsEthanolChen et al. ([@CR14])2603-*O*-α-[l]{.smallcaps}-Rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosy hederagenin 28-*O*-β-[d]{.smallcaps}-glucopyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsEthanolChen et al. ([@CR14])2613-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl hederagenin 28-*O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsEthanolChen et al. ([@CR14])2623-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl oleanolic acid-28-*O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosideUnknownUnknownXing et al. ([@CR210])2633-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 4)-β-[d]{.smallcaps}-glucopyranosyl(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl(1 → 2)-α-[l]{.smallcaps}-arabinopyranosy hederagenin 28-*O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsEthanolChen et al. ([@CR14])2643-*O*-α-[l]{.smallcaps}-Rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosy hederagenin 28-*O*-β-[d]{.smallcaps}-xylopyranosyl(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsEthanolChen et al. ([@CR14])265Macranthoidin AFlowers/FlowerEthanol1, 2, 3, 4Ren et al. ([@CR149]), Mao et al. ([@CR129])14564503266Macranthoidin BFlowers/FlowerEthanol1, 2, 3, 4Ren et al. ([@CR149]), Mao et al. ([@CR129])119025667267Macranthoside BFlowers/FlowerEthanol1, 3, 4Chai et al. ([@CR10]), Mao et al. ([@CR129])135396862268Macranthoside AFlowers/FlowerEthanol1, 3, 4Chai et al. ([@CR10]), Mao et al. ([@CR129])176534269Dipsacoside BFlowers/FlowerEthanol1, 2, 3, 4Ren et al. ([@CR149]), Mao et al. ([@CR129])21627940270Dipsacoside VIUnknownUnknownUnknownHuang et al. ([@CR66])271Hederagenin-3-*O*-α-[l]{.smallcaps}-arabinopyranosyl(2 → 1)-*O*-α-[l]{.smallcaps}-rhamnopyranosideFlowersMethanol1, 3, 4Chai et al. ([@CR10])272Hederagenin-28-*O*-β-[d]{.smallcaps}-glucopyranosyl(6 → 1)-*O*-β-[d]{.smallcaps}-glucopyranosyl esterFlower buds50% methanol1Chen et al. ([@CR16])273Thalictoside VIFlower buds70% ethanol1Chen et al. ([@CR24])23815408274Asiatic acidFlower buds70% ethanol1Chen et al. ([@CR24])119034275Leiyemudanoside AFlower budsMethanol1Liu et al. ([@CR119])276Lonimacranthoide IFlower buds50% ethanol1Chen et al. ([@CR21])277Lonimacranthoide IIFlower buds50% ethanol1Chen et al. ([@CR21])278Lonimacranthoide IIIFlower buds50% ethanol1Chen et al. ([@CR18])279Lonimacranthoide IVFlower budsEthanol1Yu et al. ([@CR226])280Lonimacranthoide VFlower budsEthanol1Yu et al. ([@CR226])281Lonimacranthoide VIFlower budsUnknown1Guan et al. ([@CR52])2822α, 24-dihydroxy-23-nor-ursolic acidFlower buds70% ethanol1Chen et al. ([@CR24])2832α, 4α-dihydroxy-23-nor-ursolic acidFlower buds70% ethanol1Chen et al. ([@CR24])284Akebia saponin DFlower buds70% ethanol1Chen et al. ([@CR24])142844362853β-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl-hederagenin-28-*O*-β-[d]{.smallcaps}-glucopyranosyl esterFlower buds70% ethanol1Chen et al. ([@CR24])2863β-*O*-α-[l]{.smallcaps}-Rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl-28-*O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl oleanolic acidFlower buds70% ethanol1Chen et al. ([@CR24])2873-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 4)-β-[d]{.smallcaps}-glucopyranosyl-(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl-23-hydroxyolean-18-en-28-oic acid *O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsMethanol1Liu et al. ([@CR119])2883-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 4)-β-[d]{.smallcaps}-glucopyranosyl-(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl-(1 → 2)-α-[l]{.smallcaps}-arabinopyranosyl\]-23-hydroxyolean lup-(2029)-en-28-oic acid *O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsMethanol1Liu et al. ([@CR119])2893-*O*-β-[d]{.smallcaps}-Glucopyranosyl-(1 → 4)-β-[d]{.smallcaps}-glucopyranosyl-(1 → 3)-α-[l]{.smallcaps}-rhamnopyranosyl-(1 → 2)-β-[d]{.smallcaps}-xylopyranosyl\]-23-hydroxyolean hederagenin *O*-β-[d]{.smallcaps}-glucopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosyl esterFlower budsMethanol1Liu et al. ([@CR119])**Essential oils**2909,12,15-Octadecatrienoic acid methyl esterFlowersAbsolute etherWang et al. ([@CR192])Flower budsDistilled water1Wu et al. ([@CR205])9316291HexadecaneFlowersAbsolute etherWang et al. ([@CR192])Flower budsEthyl acetate1Wu et al. ([@CR205])11006292NonadecaneFlowersAbsolute etherWang et al. ([@CR192])Flower budsDistilled water1Wu et al. ([@CR205])12401293Dibutyl phthalateFlowers/Flower budsAbsolute etherYang and Zhao ([@CR217])Flower budsDistilled water1Wu et al. ([@CR205])3026294Hexadecanoic acid methyl esterFlowersAbsolute etherWang et al. ([@CR192])Flower budsDistilled water1Wang et al. ([@CR188])8181295LinaloolFlowers/Flower budsAbsolute etherYang and Zhao ([@CR216])Flower budsEthyl acetate1Tong et al. ([@CR183])6549296OctadecanalFlowersAbsolute etherWang et al. ([@CR192])12533297PhytolFlowersAbsolute etherWang et al. ([@CR192])5280435298α-TerpineolFlowersAbsolute etherWang et al. ([@CR192])171002995-(Prop-2-enoyloxy)pentadecaneFlowersAbsolute etherWang et al. ([@CR192])543288300EicosaneFlowersAbsolute etherWang et al. ([@CR192])8222301TriacontaneFlowersAbsolute etherWang et al. ([@CR192])125353022,6,10-TrimethyltetradecaneFlowersAbsolute etherWang et al. ([@CR192])85785303OctadecaneFlowersAbsolute etherWang et al. ([@CR192])11635304HeptadecaneFlowersAbsolute etherWang et al. ([@CR192])12398305PentadecaneFlowersAbsolute etherWang et al. ([@CR192])12391306HexaneFlowersAbsolute etherWang et al. ([@CR192])8058307Linalool oxideFlowersAbsolute etherWang et al. ([@CR192])6431477308Methyl linolenateFlower budsDistilled waterDu et al. ([@CR36])5319706309ε-MuuroleneFlower budsDistilled waterDu et al. ([@CR36])520461310α-CurcumeneFlower budsDistilled waterDu et al. ([@CR36])92139311CarvacrolFlowers/Flower budsAbsolute etherYang and Zhao ([@CR216])10364312FarnesolFlowersDistilled waterGuan et al. ([@CR53])445070313Ascorbyl dipalmitateFlowersDistilled waterGuan et al. ([@CR53])54722209314NonacosaneFlowersDistilled waterGuan et al. ([@CR53])12409315BenzenepropanalFlower budsDistilled waterDu et al. ([@CR36])7707316EthylbenzeneFlower budsDistilled waterDu et al. ([@CR36])7500317Linalool oxide transFlower budsDistilled waterDu et al. ([@CR36])6432254318IsophytolFlower budsDistilled waterDu et al. ([@CR36])10453319CyclohexanolFlower budsDistilled waterDu et al. ([@CR36])7966320Oxalic acidFlower budsDistilled waterDu et al. ([@CR36])971321Cyclohexyl isobutyl esterFlower budsDistilled waterDu et al. ([@CR36])6421303322(Cyclopentylmethyl)cyclohexaneFlower budsDistilled waterDu et al. ([@CR36])20490323(Cyclohexylmethyl)benzeneFlower budsDistilled waterDu et al. ([@CR36])324AromadendreneUnknownUnknownWang ([@CR186])91354325GeraniolUnknownUnknownWang ([@CR186])637566326(Z)-JasmoneFlowersHexaneIkeda et al. ([@CR67])1549018327(Z)-Jasmin lactoneFlowersHexaneZhang ([@CR231])328Methyl jasmonateFlowersHexaneZhang ([@CR231])5281929329Methyl epi-jasmonateFlowersHexaneZhang ([@CR231])5367719330BenzaldehydeFlowers/Stems/LeavesDistilled waterWu et al. ([@CR204])240331Diethyl phthalateFlowers/Stems/LeavesDistilled waterWu et al. ([@CR204])6781332PropylbenzeneFlowersDiethyl etherDu et al. ([@CR35])7668333TranslinaloolFlowersDiethyl etherDu et al. ([@CR35])334Cyclohexylisooxalic esterFlowersDiethyl etherDu et al. ([@CR35])335MethylcyclohexaneFlowersDiethyl etherDu et al. ([@CR35])79623361-OctanolFlowersAbsolute etherWang et al. ([@CR192])9673375-Octen-1-olFlowersAbsolute etherWang et al. ([@CR192])622313381-OctadecanolFlowersAbsolute etherWang et al. ([@CR192])8221339HeptanalFlowersAbsolute etherWang et al. ([@CR192])8130340OctanoneFlowersAbsolute etherWang et al. ([@CR192])8093341Acetic acid ethyl esterFlowersAbsolute etherWang et al. ([@CR192])8857342Benzeneacetic acid methyl esterFlowersAbsolute etherWang et al. ([@CR192])7559343Docosanoic acid methyl esterFlowersAbsolute etherWang et al. ([@CR192])13584344Tetracosanoic acid methyl esterFlowersAbsolute etherWang et al. ([@CR192])75546345Benzyl benzoateFlowersAbsolute etherWang et al. ([@CR192])23453466,10,14-Trimethyl-2-pentadecanolFlower budsDistilled water1Wang et al. ([@CR188])530418347Dimethyl phthalateFlower budsDistilled water1Wu et al. ([@CR205])8554348Octadecanoic acidFlower budsDistilled water1Wu et al. ([@CR205])52813491,2,3-Propanetriol, monoacetateFlower budsEthyl acetate1Wu et al. ([@CR205])335103509,12-Octadecadien-1-olFlower budsEthyl acetate1Wu et al. ([@CR205])546291235110-NonadecanolFlower budsEthyl acetate1Wu et al. ([@CR205])85611352HeneicosaneFlower budsEthyl acetate1Wu et al. ([@CR205])12403353Hexadecanoic acid butyl esterFlower budsDistilled water1Wu et al. ([@CR205])80903543,7,11,15-Tetramethyl-2-hexadecen-1-olFlower budsEthyl acetate1Wu et al. ([@CR205])5366244355Phenylethyl alcoholFlower budsDistilled water1Wu et al. ([@CR205])60543561-HexadecanolFlower budsDistilled water1Wu et al. ([@CR205])2682357Heptadecane,2,6,10,15-tetramethyl-3-Hydroxy-2,2,6-trimethyl-6-vinyltetrahydropyranFlower budsDistilled water1Wu et al. ([@CR205])358NerolFlower budsDistilled water1Wu et al. ([@CR205])643820359Benzoic acid, 4-formyl methyl esterFlower budsDistilled water1Wu et al. ([@CR205])15294360Undecanoic acidFlower budsDistilled water1Wu et al. ([@CR205])818036112,15-Octadecadienoic acid, methyl esterFlower budsDistilled water1Wu et al. ([@CR205])53655713629,12,15-Octadecatrienoic acid, methyl esterFlower budsDistilled water1Wu et al. ([@CR205])53674623639,12,15-Octadecatrien-1-olFlower budsDistilled water1Wu et al. ([@CR205])53673273641-HeptacosanolFlower budsEthyl acetate1Wu et al. ([@CR205])74822365PentatriacontaneFlower budsEthyl acetate1Wu et al. ([@CR205])12413366Pentanoic acid ethyl esterFlower budsEthyl acetate1Wu et al. ([@CR205])10882367Hexanoic acidFlower budsEthyl acetate1Wu et al. ([@CR205])8892368Di-isobutyl phthalateFlower budsEthyl acetate1Wu et al. ([@CR205])67823692-NonadecanoneFlower budsEthyl acetate1Wu et al. ([@CR205])69423370TetracosaneFlower budsEthyl acetate1Wu et al. ([@CR205])12592371Octadecanoic acid butyl esterFlower budsEthyl acetate1Wu et al. ([@CR205])31278372Acetic acid octadecyl esterFlower budsEthyl acetate1Wu et al. ([@CR205])69968373Citronellyl isobutyrateFlower budsEthyl acetate1Wu et al. ([@CR205])60985374Eicosanoic acidFlower budsEthyl acetate1Wu et al. ([@CR205])10467**Others***Aliphatics*375Linoleic acidFlower budsDiethyl etherDu et al. ([@CR36])Flower budsDistilled water1Wu et al. ([@CR205])5280450376Tetradecanoic acidFlowers/Flower budsAbsolute etherWang et al. ([@CR192])Flower budsDistilled water1Wu et al. ([@CR205])11005377Ethyl laurateFlower buds95% ethanolJiang ([@CR76])7800378NonacontaneFlower budsUnknownWang ([@CR185])189806723792(E)-3-ethoxyacrylic acidFlowers/Flower budsChloroformBi et al. ([@CR5])5709609*Phenols*380Lonicerjaponin AFlower budsMethanolKashiwada et al. ([@CR86])102497708381Lonicerjaponin BFlower budsMethanolKashiwada et al. ([@CR86])1024977093823,4-DihydroxybenzaldehydeFlowers/Flower budsAlcoholHuang et al. ([@CR64])8768383p-HydroxybenzaldehydeFlowers/Flower budsEthyl acetateWang et al. ([@CR196])126384P-Hydroxy-phenolFlower budsAcetoneFeng et al. ([@CR44])7853851,2,4-BenzenetriolFlower budsAcetoneFeng et al. ([@CR44])10787*Nucleosides*3865′-*O*-MethyladenosineFlower budsDistilled waterSong et al. ([@CR167])6480505387GuanosineFlower budsDistilled waterSong et al. ([@CR167])135398635388AdenosineFlower budsDistilled waterSong et al. ([@CR167])60961389UracilFlowers/Flower budsEthyl acetateWang et al. ([@CR196])11743905-MethyluracilFlowers/Flower budsEthyl acetateWang et al. ([@CR196])1135391Guanosinyl-(3′ → 5′)-adenosine monophosphateFlowers/Flower budsDistilled waterYu et al. ([@CR229])3922′-*O*-MethyladenosineFlowers/Flower budsDistilled waterYu et al. ([@CR229])102213*Alkaloids*393Lonijaponinicotinosides AFlower budsDistilled waterJiang et al. ([@CR79])394Lonijaponinicotinosides BFlower budsDistilled waterJiang et al. ([@CR79])395(+)-*N*-(3-Methybutyryl-β-[d]{.smallcaps}-glucopyranoyl)-nicotinateFlower budsDistilled waterSong ([@CR165])396(+)-*N*-(3-Methybut-2-enoyl-β-[d]{.smallcaps}-glucopyranosyl)-nicotinateFlower budsDistilled waterSong ([@CR165])3976-Hydroxymethyl-3-pyridinolFlowers/Flower budsDistilled waterYu et al. ([@CR229])*Triterpenoids*398LimoninUnknownUnknownZhen ([@CR238])179651*Sesquiterpenoids*399Abscisic acidFlowers/Flower budsEthyl acetateWang et al. ([@CR196])5375199*Sterols*400β-SitosterolFlowers/Flower budsAlcoholHuang et al. ([@CR64])222284*Saccharides*401SucroseFlower buds70% ethanolLee et al. ([@CR101])5988*Lignans*402(−)-Lyoniresinol 9-*O*-β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])403(+)-Lyoniresinol 9-*O*-β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])*Aromatic glycosides*404(−)-2-Hydroxy-5-methoxybenzoic acid 2-*O*-β-[d]{.smallcaps}-(6-*O*-benzoyl-glucopyranoside)Flower budsEthyl acetateWang et al. ([@CR197])405(−)-4-Hydroxy-3,5-dimethoxybenzoic acid 4-*O*-β-[d]{.smallcaps}-(6-*O*-benzoyl)-glucopyranosideFlower budsEthyl acetateWang et al. ([@CR197])406(−)-E-3,5-Dimethoxyphenyl-propenoic acid 4-*O*-β-[d]{.smallcaps}-(6-*O*-benzoyl)-glucopyranosideFlower budsEthyl acetateWang et al. ([@CR197])407(−)-(7S,8R)-4-Hydroxyphenylglycerol 9-*O*-β-[d]{.smallcaps}-\[6-*O*-(E)-4-hydroxy-3,5-dimethoxyphenylpropenoyl\]-glucopyranosideFlower budsEthyl acetateWang et al. ([@CR197])408(−)-(7S,8R)-(4-Hydroxyphenylglycerol9-*O*-β-[d]{.smallcaps}-\[6-*O*-(E)-4-hydroxy-3,5-dimethoxyphenylpropenoyl\]-glucopyranosideFlower budsEthyl acetateWang et al. ([@CR197])409(−)-4-hydroxy-3-Methoxyphenol β-[d]{.smallcaps}-{6-*O*-\[4-*O*-(7S,8R)-(4-hydroxy-3-methoxyphenylglycerol-8-yl)-3-methoxybenzoyl\]}-glucopyranosideFlower budsEthyl acetateWang et al. ([@CR197])410Benzyl alcohol β-[d]{.smallcaps}-glucosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])411Benzyl 2-*O*-β-[d]{.smallcaps}-glucopyranosyl-2,6-dihydroxybenzoateFlowers/Flower budsEthyl acetateWang et al. ([@CR196])412Gentisic acid 5-*O*-β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])413Eugenyl β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])3084296414Eugenyl β-[d]{.smallcaps}-xylopyranosyl-(1 → 6)-β-[d]{.smallcaps}-glucopyranosideFlowers/Flower budsEthyl acetateWang et al. ([@CR196])*Miscellaneous*4152-ButanolUnknownUnknownWang et al. ([@CR192])65684161-*O*-Methyl-myo-inositolFlower budsUnknownWang ([@CR185])440078417SyringinFlowers/Flower budsDistilled waterYu et al. ([@CR229])5316860418ConiferinRoots95% ethanolJin-qian et al. ([@CR80])52803724195-Hydroxymethyl-2-furfuralFlowers/Flower budsMethanolChoi et al. ([@CR28])237332420ShuangkangsuFlowersUnknownWang ([@CR185])421Citric acidFlowers/Flower budsDistilled water1Zhang et al. ([@CR233])3111---*L. macranthoides*, 2---*L. fulvotomentosa*, 3---*L. hypoglauca*, 4---*L. confusa*Fig. 2The major phenolic acids presenting in both JYH and SYHFig. 3The major flavonoids presenting in both JYH and SYHFig. 4The major iridoids presenting in both JYH and SYHFig. 5The chemical structures of main saponins in SYHTable 5Differences in content (mg/g) of major compounds isolated from JYH or SYHCompoundExtractionJYHSYHReferences*L. macranthoidesL. hypoglaucaL. confusaL. fulvotomentosa*Phenolic acids **1**Methanol2.931 ± 0.0105.657 ± 0.010Yang et al. ([@CR218])Flavonoids **88**70% methanol0.472 ± 0.0100.060 ± 0.0100.009 ± 0.0100.057 ± 0.0100.173 ± 0.010Zhang et al. ([@CR234]) **125**Methanol0.951 ± 0.0080.081 ± 0.003tr0.011 ± 0.008ndXiong et al. ([@CR211]) **126**Methanol0.093 ± 0.001nd0.029 ± 0.0020.059 ± 0.001ndXiong et al. ([@CR211])Iridoids **143**70% methanol0.242 ± 0.0100.120 ± 0.010nd0.056 ± 0.0100.245 ± 0.010Li et al. ([@CR110]), Zhang et al. ([@CR234])Saponins **265**70% methanolnd6.90 ± 0.0204.13 ± 0.0806.46 ± 0.1403.78 ± 0.070Zhang et al. ([@CR234]) **266**70% methanolnd51.81 ± 0.67024.68 ± 0.24054.68 ± 0.3001.06 ± 0.020Zhang et al. ([@CR234]) **267**Methanolnd1.79 ± 0.031.72 ± 0.022.04 ± 0.04nrChai et al. ([@CR10]) **268**Methanolnd1.25 ± 0.032.23 ± 0.06trnrChai et al. ([@CR10]) **269**70% methanolnd12.16 ± 0.13019.28 ± 0.3006.10 ± 0.12040.96 ± 0.140Zhang et al. ([@CR234])*tr* trace, *nd* not detect, *nr* no recordTable 6The activities of some compounds isolated from JYH or SYHEffectOriginsCompoundsModel/targetsPositive controlFormulation/dosageResult/mechanism/methodReferencesAnti-inflammatory activityJYH**1--6**, **62**, **69**LPS-induced macrophageIn vitro50 μg mL^−1^Inhibited NO production, TNF-α and IL-6 secretionSong et al. ([@CR170])**238**Croton oil-induced ear edema mouseAdministered orallyReference compounds prednisolone showed potent inhibition 57.9% inhibition at 10 mg kg^−1^ and aspirin weakly inhibited ear edema 15.0% inhibition at 100 mg kg^−1^In vivo100 mg kg^−1^Inhibited ear edema 31%Kwak et al. ([@CR93])1**281**RAW264.7 macrophagesThe presence of Indomethacin10 μmol L^−1^ only produced a significant reduction of COX-2 mRNA expressionIn vitro10 and 100 μmol L^−1^Inhibited mRNA expression and COX-2 activity in a dose-dependent manner. Only high concentration 100 μmol L^−1^ reduced COX-1 expressionGuan et al. ([@CR52])**282**, **283**LPS-activated RAW264.7 cellsBetamethasone, 30 μmol L^−1^In vitro30 μmol L^−1^Inhibited expression of pro-inflammatory proteins iNOS and NO releasingMei et al. ([@CR130])Bacteriostatic activityJYH and SYH**1**, **4***P. aeruginosa*The most correlated compounds against antibacterial activities assayed by canonical correlation analysisShi et al. ([@CR161])Antiviral activityJYH**1**, **62** and quinic acidHepG2.2.15 cells cultured for 8 days in the presence or absence of **1**, **62** and quinic acidDuck hepatitis B virus DHBV-infected duckling modelAdministered orallyLamivudineIn vitroExhibited an inhibition of HBsAg secretion at a IC~50~ value of 295 μMIn vivoInhibitory efficacy 50 mg kg^−1^ was lower than that of **1** and **62**In vitro0.14 to (1000) μg L^−1^In vivo100 mg kg^−1^In vitro**1** and **62** inhibited HBsAg secretion at an IC~50~ value of 242 μM and 13 μM, but showed little inhibition of HBeAg secretion at a dose up to (1000) μMIn vivo**1** and **62** reduced the DHBV viremia significantly while DHBV viremia was slightly changed by quinic acid, indicating **1** and **62** having potent anti-HBV activitiesWang et al. ([@CR190])JYH**1--4**, **6**H1N1 virusRibavirin, 20 mg kg^−1^The order of antiviral intensities was ranked as followed, **4 **≈ **3** \> **2** ≈ **1 **≈ **6**Zhou et al. ([@CR242])JYH**148**, **200**H1N1 virusOseltamivir carboxylate, 100 μg mL^−1^ 45.5% inhibitionIn vitro100 μg mL^−1^**148** and **200** had inhibitory activities against H1N1 replication inhibitory rates were 53.1% and 49.3%, respectivelyKashiwada et al. ([@CR86])Anti-tumour activity1**267**Tumour cell lines of different histogenetic origins four leukaemia types, HL-60, U-937, Jurkat and K-562. Two solid tumour-derive types, LoVo and Hep G2In vitro5, 10, 15 and 20 μmol L^−1^Inhibited cell growth of six cancer cell lines, especially human acute promyelocytic leukaemia HL-60 cells, with an IC~50~ value of 3.8 mmol. After 24 h and 48 h treatment, a hypodiploid cells assay and an annexin-V-FITC/PI double staining assay showed that there was a significant increase of apoptosis on HL-60 cells in a dose-dependent manner through caspase-mediated pathway, by activation of caspase-3Guan et al. ([@CR51])1**267**Human ovarian cancer A (2780) cellsIn vitro5, 10 and 20 μmol L^−1^Induced apoptosis and autophagy via reactive oxygen species ROS which could activate caspase-3 and caspase-9, cleave poly adenosinediphosphate-ribose polymerase, regulate adenylate-activated protein kinase, and inhibited mammalian target of rapamycin. Inhibits 70% colony formation at the concentration of 20 μmol L^−1^Shan et al. ([@CR156])1**267**Human hepatoma HepG2 cellsFemale athymic BALB/cA nude mouseIntravenous injectionCyclophosphamide, 25 mg kg^−1^In vitroHad little inhibitory effectIn vivoTumors in mice treated with **267** and Cyclophosphamide resulted in 53.29% and 68.58% inhibitionIn vitro4.25, 7.08, 14.75, 23.04, 48.00 μmol L^−1^In vivo5 mg kg^−1^In vitroWith concentration increasing, the inhibitory rates increased 2.58, 23.21, 55.89, 86.55 and 98.14%, with IC~50~ value of 10.10 ± 0.93 μMIn vivoThe volume and weight of xenograft tumors in mice were decreased remarkably *P* \< 0.05Wang et al. ([@CR191])1---*L. macranthoides*

Phenolic acids {#Sec8}
--------------

JYH and SYH contain similar phenolic acids that are important bioactive compounds in JYH and SYH (Duan et al. [@CR37]). There are 16 phenolic acids presenting in both JYH and SYH, most of which are caffeic acid derivatives. According to 2015 Edition ChP, the content of chlorogenic acid **(1**, CGA**)** in JYH must be no less than 1.5%, while the content of CGA (**1**) in any origin of SYH must be no less than 2.0%. SYH total phenolic acids content is also higher than that of JYH (Yang et al. [@CR218]). Four origins of SYH contain similar chlorogenic acids derivatives. May be the cause of insufficient researches of SYH, *L. macranthoides* contains more phenolic acids than the other three origins.

The antioxidative property is closely related to the structure, in particular to electron delocalization of the aromatic nucleus (Cuvelier et al. [@CR32]). As it is widely known, a number of naturally occurring molecules known for their antioxidative potency are phenolic acids which react with the free radicals and generate a new radical stabilized by the resonance effect of the aromatic nucleus (Larson [@CR94]). Meanwhile, the presence of a second hydroxy group in the *ortho* or *para* position of phenolic acids could increase their antioxidant capacity. A wide range of researches demonstrate that changes of antioxidant intensity are always closely associated with the variation of the contents of phenolic acids (Porter et al. [@CR144]; Farhat et al. [@CR41]; Ben Farhat et al. [@CR4]).

CGA (**1**) and caffeic acid (**62**, CA) are the two most studied compounds in JYH and SYH, which have already been confirmed to possess potent activities against inflammation and oxidation via removing harmful free radicals from body in vitro and in vivo (Feng et al. [@CR43]; Chen et al. [@CR19]; Sato et al. [@CR152]). CGA containing an *O*-hydroquinone moiety is the most abundant phenolic acid in JYH and SYH, and it has been used as a marker to evaluate chemical qualities of JYH and SYH according to 2015 Edition ChP (Chen et al. [@CR26]; Li et al. [@CR114]; Iwahashi et al. [@CR69]). CGA is an ester of CA and quinic acid, and CA showed the strongest anti-inflammatory activity among **1--6**, **62** and **69** in vitro (50 μg mL^−1^) (Song et al. [@CR170]). In addition, both CGA and CA can inhibit nitric oxide (NO) production, tumor necrosis factor-α (TNF-α) and IL-6 secretion below 100 μg mL^−1^, and exert effects on multiple targets, such as pro-inflammatory protein inducible nitric oxide synthase (iNOS), toll-like receptor 4, interleukin (IL)-1 receptor, matrix metalloproteinase-2 and 9 in vitro and in vivo, suggesting developing values (shown in Fig. [6](#Fig6){ref-type="fig"}) (Lee et al. [@CR103]; Shi et al. [@CR160]; Hou et al. [@CR62]; Kim et al. [@CR88]; Rubio et al. [@CR151]). By reinforcing immune-resistance to bacteria and stimulating the activity of lysozym, CA affects the growth of some Gram-negative bacteria directly, such as *Pseudomonas fluorescens* (Ferrazzano et al. [@CR45]).Fig. 6Proposed molecular mechanisms of anti-inflammatory activities of CGA **(1)** and CA **(62)**. *LPS* lipopolysaccharide, *IL-1* interleukin, *MyD88* myeloid differentiation primary response gene 88, *ACP* acyl carrier protein, *IRAK* interleukin receptor associated kinase, *IκBα* I kappa B alpha, *NF-κB* nuclear factor κB, *TLR4* toll-like receptor 4, *TIRAP* toll-interleukin 1 receptor domain-containing adapter protein, *TOLLIP* toll interacting protein, *PKR* double-stranded RNA-dependent protein kinase, *CGA* chlorogenic acid, *CA* caffeic acid, *TRAF2* TNF receptor-associated factor 2, *TAK1* transforming growth factor activated kinase-1, *NIK* NF-κB inducing kinase, *IKKs* inhibitor of NF-κB kinases, *COX-2* cyclooxygenase-2, *iNOS* inducible nitric oxide synthase

Zhou investigated the pharmacokinetics and tissue distribution of CGA via oral administration. Employing noncompartment model, profile revealed CGA the low oral bioavailability (*t*~max~ = 0.58 ± 0.13 h, *C*~max~ = 1490 ± 0.16 μg L^−1^), and tissue study showed that the highest level of CGA was in liver (Zhou et al. [@CR240]). To study the bioavailability of CGA that extracted from JYH, Zhou gave 42 rats 400 mg kg^−1^ JYH 85% ethanol extractions (yielding an extraction with the content of 16.7% CGA) by intravenous (i.v), intramuscular (i.m) and intragastrical (i.g) administration. t~1/2~ of i.v, i.m and i.g administration were 0.44, 0.50 and 0.38 h, and AUC~0→∞~ were 6931.62, 6550.34 and 2591.87 μg h L^−1^. The absolute bioavailability of CGA by i.g administration was only 37.39% (Ting et al. [@CR181]). Chen developed a self-microemulsifying drug delivery system (SMEDDS) to improve the oral bioavailability of CGA. Compared with control group (CGA alone, *t*~max~ = 0.1 h, *C*~max~ = 82.6 μg mL^−1^), CGA-SMEDDS group had a peak concentration of 47.6 μg mL^−1^ and the peak time was delayed to 2.4 h (Chen et al. [@CR26]).

Phenolic acids are typically regarded as actives in a variety of bioassays as the above said, yet it should be stressed that orthoquinone substances readily display false-positive activities and act as interference in unrelated biological activities. The orthoquinone motif is characteristic of Pan Assay INterference compoundS, or PAINS (Baell [@CR1]). CA and its derivatives, for instance, containing the recognizable PAINS motif (catechol), have a tendency to cause assay artifacts. Compounds with such functional group could undergo redox cycling, chelatesmetal, perturb membranes and appeared with signs of early structure--activity relationship (SAR) (Jasial et al. [@CR70]; Baell and Holloway [@CR2]), thus attracting attention of researchers and inevitably leading all efforts to be in vain.

Flavonoids {#Sec9}
----------

Flavonoids are a group of structurally diverse natural or synthetic compounds which include parent cyclic structures and their *O*- and *C*-glycosylated derivatives (Rauter et al. [@CR147]). So far, 52 and 16 flavonoids have been found in JYH and SYH, 14 of which are identical. Researches on flavonoids in SYH should be further developed. In view of the current limited research, *L. confusa* has more flavonoids than the other three origins of SYH.

This class of compounds is mainly flavonols and flavones, and most of them are glycosides. Their health benefits are particularly associated with the prevention of chronic degenerative diseases such as cancer, diabete and cardiovascular disease (Scalbert et al. [@CR153]; Ramassamy [@CR146]). Luteolin **(89)** is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3′, 4′, 5 and 7. It has been reported to possess anti-angiogenic activity in human umbilical vein endothelial cells and human retinal microvascular endothelial cells (below 5 μM, in vitro), which contributed to the inhibition on the pathogenesis of retinopathy of prematurity and tumor growth (Eleni et al. [@CR38]; Park et al. [@CR139]). Luteolin **(89)**, as well as cynaroside (**88**) a derived glycoside of luteolin that is substituted by a β-[d]{.smallcaps}-glucopyranosyl moiety at the position 7 via a glycosidic linkage of luteolin, is active against inflammation. Odontuya reported that the anti-inflammatory effect of luteolin and cynaroside was dependent on their molecular structures, that is to say the presence of *ortho*-dihydroxy groups at the B ring and hydroxy substitution pattern at C-5 position of the A ring could significantly contribute to anti-inflammatory and antioxidant activities of flavones (Odontuya et al. [@CR133]).

Iridoids {#Sec10}
--------

Iridoids are the main water-soluble compounds in JYH and SYH, mostly presenting as glycosides (Yang et al. [@CR218]). So far, 92 and 8 iridoids have been isolated and identified from JYH and SYH. JYH and SYH contain similar iridoids (7 out of 8 SYH iridoids could be isolated from JYH). Compared to the other three SYH plant origins, *L*. *fulvotomentosa* contains relatively few iridoids and only sweroside **(143)** has been isolated. Iridoid glycosides in JYH include loganin **(142)**, loganic acid **(189)**, 8-epiloganic acid **(190)**, among others. Secoiridoids in JYH are sweroside **(143)**, secologanoside **(144)**, secoxyloganin **(148)**, secologanin **(150)**, among others, and they are the main iridoids in SYH. In addition, JYH and SYH also contain a dimer iridoid glycoside centauroside **(146)**, with structure linked by a C--C double bond.

Secoxyloganin (**148**) and dimethylsecologanoside (**200**, both at 100 μg mL^−1^) displayed inhibitory activities (53.1% and 49.3%, respectively) against influenza A virus (H1N1), while the positive control oseltamivir carboxylate (100 μg mL^−1^) showed 45.5% inhibitory rate (Kashiwada et al. [@CR86]). Lonijaposides O, R, T and W (**221**, **224**, **226**, **229**) were also reported antiviral activities against H1N1 with half maximal inhibitory concentration (IC~50~) values of 6.8--11.6 μM. The positive control, oseltamivir, gave an IC~50~ value of 1.3 μM (Yu et al. [@CR227]). Centauroside (**146**) and (E)-aldosecologanin (**185**) exhibited much more potent NO inhibitory activities than the positive control minocycline in vitro (IC~50~ = 20.07 ± 0.37 μM), with IC~50~ values of 7.96 ± 0.47 and 12.60 ± 1.50 μM, respectively. What's more, neither of them showed significant cytotoxicity at the concentration of 100 μM (Liu et al. [@CR120]). In this literature, it also mentioned that secoiridoid glycosides had a more positive effect on α-glucosidase inhibition than other iridoid glycosides, while the presence of a methoxy group at C-7 or a double bond at C-6 or C-7 appeared to reduce the inhibition markedly.

Saponins {#Sec11}
--------

A large number of studies indicate that saponins contented in JYH are fewer than those in SYH (Li et al. [@CR110]; Chai et al. [@CR10]; Zhang et al. [@CR234]; Yang et al. [@CR218]). Saponins are the most compounds in SYH (Fig. [5](#Fig5){ref-type="fig"}), and most of them belong to the oleanane type or hederagenin type. Although most researches focus on *L. macranthoides*, macranthoidin A **(265)**, macranthoidin B **(266)** and dipsacoside B **(269)** which are the representative saponins in SYH, have been isolated from all four origins of SYH. It was relatively easy to distinguish *L. fulvotomentosa* from the other three SYH origins for *L. fulvotomentosa* having a relative low content of macranthoidin B **(266)** (Zhang et al. [@CR234]; Chen et al. [@CR16]; Zhou et al. [@CR240]; Gao et al. [@CR47]). Macranthoidin B **(266)** and dipsacoside B **(269)** have been used as markers to evaluate the chemical quality of SYH, whereas they are trace in JYH.

Studies showed that these saponins have anti-tumour and anti-inflammatory activities in vitro and in vivo (Kwak et al. [@CR93]; Mei et al. [@CR130]; Shan et al. [@CR156]). In recent years, macranthoside B **(267)** has provoked mounting attention due to its anti-tumour activity both in vitro and in vivo with IC~50~ values in the range of 3.8--20 μM, and it could inhibit growth of various tumour cells through caspase-3 and caspase-9 pathways (shown in Fig. [7](#Fig7){ref-type="fig"}) (Guan et al. [@CR51]; Shan et al. [@CR156]; Wang et al. [@CR191]). Loniceroside C **(238)**, macranthoside A **(268)**, dipsacoside B **(269)** and dipsacoside VI **(270)** have been reported anti-inflammatory activities both in vitro and in vivo (Kwak et al. [@CR93]; Lee et al. [@CR98]; Guan et al. [@CR52]; Mao et al. [@CR129]), associating with many targets, such as prostaglandin E2 (PGE2), cyclooxygenase (COX)-1, COX-2, etc. In RAW264.7 macrophages, over-production of PGE2 was induced by lipopolysaccharide (LPS). Measuring COX activity and mRNA expression, the results showed that lonimacranthoide VI (**281**, 10 μmol L^−1^) from *L. macranthoides* could inhibit mRNA expression and COX-2 activity in vitro, indicating lonimacranthoide VI **(281)** an important anti-inflammatory compound of SYH (Guan et al. [@CR52]). However, available evidence indicates that saponins have the potentiality to trigger cytotoxicity, and the sequence α-[l]{.smallcaps}-Rha*p*-(1 → 2)-α-[l]{.smallcaps}-Ara*p* in oleanolic acid or hederagenin is the characteristic of a more cytotoxic saponin (Park et al. [@CR136]; Barthomeuf et al. [@CR3]; Chwalek et al. [@CR30]). This part will be discussed in Toxicology.Fig. 7Proposed molecular mechanisms of anti-tumour activitiy of macranthoside B **(267)**. *TNF* tumor necrosis factor, *IAP* immunosuppressive acidic protein, *PARP* poly adenosinediphosphate-ribose polymerase, *APAF-1* apoptotic protease activating factor-1, *Cyt-c* cytochrome c, *AMPK* adenosine 5′-monophosphate-activated protein kinase, *mTOR* mammalian target of rapamycin, *S6K1* p70 S6 kinase 1, *Bcl-2* B cell lymphoma-2, *Bax* B-cell lymphoma-2 associated X protein, *ROS* reactive oxygen species

Essential oil {#Sec12}
-------------

The aromas of JYH and SYH are unique and they both contain a large amount of essential oils which are edible natural perfume used in food, cigarettes and cosmetics (Wang et al. [@CR189]). Essential oils of JYH and SYH are mainly composed of acids, aldehydes, alcohols, ketones and their esters, such as hexadecane **(291)**, nonadecane (**292**), hexadecanoic acid methyl ester (**294**). The content of acids in essential oils of JYH is relatively high, reaching 8.53% (Wu et al. [@CR204]), while the content of linalool **(295)** in essential oils of SYH is the highest (Tong et al. [@CR183]).

Others {#Sec13}
------

Nucleosides, alkaloids, triterpenoids, etc. have also been isolated from JYH. Citric acid (**421**) has been isolated from SYH. In 2008, Li isolated a new compound with an unusual 1,2-dioxine skeleton, Shuangkangsu (**420**). It has prominent antiviral activity against influenza B virus and influenza A3 virus with treatment index (TI) greater than 32 (*P* \< 0.5), and inhibits respiratory syncytial virus significantly with an IC~50~ value of 0.9 mg mL^−1^ (Li [@CR106]).

Pharmacological activities {#Sec14}
==========================

Modern pharmacological studies have revealed that JYH and SYH exhibit extensive range of biological activities. According to 2015 Edition ChP, they have same therapeutic actions. However, the reported studies indicated that some of their pharmacological effects are different, especially the discrepant intensities caused by the variation of bioactive compounds. This section describes the pharmacological activities of JYH and SYH, and presents their differences and similarities by reviewing their pharmacological studies (Table [7](#Tab7){ref-type="table"}).Table 7The modern pharmacological studies of JYH and SYHEffectOriginsExtractsModelFormulation/dosageResult/methodReferenceAnti-inflammatory activityJYHWaterTrypsin-induced mast cellIn vitro10, 100 and 1000 μg mL^−1^Inhibits TNF-α secretion in a dose-dependent manner and trypsin-induced ERK phosphorylation. At the concentration of 100 μg mL^−1^, significantly inhibits TNF-α secretion. At the concentration of 1000 μg mL^−1^, inhibits TNF-α secretion up to 71%Kang et al. ([@CR84])LPS-induced rat liver sepsisIn vitro100 mg kg^−1^Inhibits the increase of NF-κBp65 and the degradation of I-κBαLee et al. ([@CR99])Macrophage-like cell line (RAW 264.7 cells)In vitro2.0 mg mL^−1^Inhibits 66% NO production and 70% TNF-α secretion. Even at low concentration (0.0625 mg mL^−1^), TNF-α secretion is also significantly inhibited (*P* \< 0.05)Park et al. ([@CR137])LPS-induced acute lung inflammation mouseAdministered orallyIn vivo0.4 mg kg^−1^, 4 mg kg^−1^ and 40 mg kg^−1^Enhances the expression of IL-10 and decreases the NF-κB binding activities by increasing the nuclear Sp1 binding activity (the up-regulation of Sp1 activity is through incremental phosphorylation of ERK). Therefore, inhibites the expressions of TNF-α, IL-1β and IL-6, and the protein concentrations and nitrite/nitrate ratios in BALFs of mouse exposed to LPS are significantly suppressedKao et al. ([@CR85])JYH and 1Cigarette smoke extract-induced acute stomatitis KB cellsIn vitroJYH: 0.1532, 1.532, 15.32, 153.19, 306.38, 612.77 μg mL^−1^SYH: 0.1645, 1.645, 16.45, 164.54, 329.08, 658.16 μg mL^−1^Inhibit the expressions of TNF-α, IL-6 and IL-8, and improve low expression of IL-10 in a dose-dependent mannerLi et al. ([@CR115])Total saponins of 2UnknownOvalbumin-induced inflammation mouseIn vivo200 mg kg^−1^Effectively reduce the over expressions of IL-6 and IL-17A, and significantly enhance the expressions of CD4^+^ and CD25^+^, and make T cell specific transcription factor Foxp3 regularityFeng and Li ([@CR42])Bacteriostatic activityJYHWaterIn vitro40 mg mL^−1^Against *Bacillus cereus*, *Listeria monocytogenes*, *Staphylococcus aureus*, *Escherichia coli*, and S*almonella anatum* (intensity: *E. coli* \> *S. aureus* \> *B. cereus* \> *S. anatum* \> *L. monocytogenes*)Gram-positive bacteria are generally more sensitive than Gram-negative bacteria to JYHShan et al. ([@CR155])In vitro10 mg mL^−1^Against oral pathogenic microorganismsBi et al. ([@CR6])3, 4In vitro20 g kg^−1^Against *S. aureus*, *Typhoid bacillus* and *Dysentery bacillus*.The inhibitory effects of *L. confuse* are higher than those of *L. hypoglauca*Li and Cui ([@CR107])JYH and 1In vivo100 mg mL^−1^Prolong the survival time of *S. aureus*-infected mouse significantly (*P* \< 0.01)Lei et al. ([@CR104])Antiviral activityJYHAgainst human immunodeficiency virus, adenovirus, herpes simplex virus-1 (HSV-1), HSV-2 and H1N1Zhou et al. ([@CR242]), Ou et al. ([@CR135])SYHAgainst NDV, PRVWang et al. ([@CR193]), Wang et al. ([@CR194])Liver protective activityJYHAP-induced liver injury mouseIn vivo350 mg kg^−1^Inhibits the increase of AP-induced alanine and aspartate transaminases (ALT/AST) enzymatic activities, as well as total bilirubin (TB) amountJiang et al. ([@CR78])Dimethylnitrosamine (DMN)-induced acute liver injury wistar ratsIn vivo200 mg mL^−1^Liver fibrosis is significantly reducedSun et al. ([@CR171])2Ethylphthalide aminophenol (AM)-induced hepatotoxicity mouseIn vivo100 mg kg^−1^Enhances the detoxification of liver to AM and alleviates mouse liver injuryShi and Liu ([@CR158])JYH and SYHCCl~4~-induced liver injury mouseIn vivo200 mg kg^−1^Decrease serum glutamic-pyruvic transaminase, liver triglyceride and MDA levels significantly (*P* \< 0.05)Tang et al. ([@CR174])Antioxidative activityJYHHigh pressure steam-scalded mouseIn vivo1 g mL^−1^Polymorphonuclear (PMN) lysyme release rate reduces significantlyLuo et al. ([@CR124])SYHIn vitro250 μg mL^−1^Scavenges O2^−^· and ·OH effectively.Wu et al. ([@CR206]), Xu et al. ([@CR215])Hypoglycemic activityJYH polysaccharidesSTZ-inducd diabetic ratsIn vivo800 mg kg^−1^The contents of liver and skeletal muscle glycogen and the concentrations of hepatic pyruvate kinase and hexokinase increases, together with significant declining of total cholesterol, totaltriglyceride, low-density and very-low-density lipoprotein-cholesterin and significant rising of high-density lipoprotein-cholesterin. Inhibit the increasing sugar, insulin levels and the food and water intake.Wang et al. ([@CR200]), Zhao et al. ([@CR237])SYH polysaccharideSTZ-induced diabetic ratsAdministered orallyIn vivo800 mg kg^−1^Anti-tumour activityJYH polyphenolicHuman hepatoma HepG2 cell lineIn vitro10 mg mL^−1^Decreases the expressions of cyclin dependent kinase 1, cyclin B1, pro-caspases-3, pro-caspases-9 and poly adenosine diphosphate ribose polymerase. The phosphorylation of ERK ½, c-Jun N-terminal kinase (JNK), and MAPKs are increased, whereas Akt is dephosphorylated.Park et al. ([@CR138])1---*L. macranthoides*, 2---*L. fulvotomentosa*, 3---*L. hypoglauca*, 4---*L. confusa*

Anti-inflammatory activity {#Sec15}
--------------------------

TNF-α, a major inflammatory mediator exerts systemic inflammatory properties such as fever and tissue damage, and possesses a broad spectrum of biologic activities on many different targets. NO has a significant role in homeostasis and host defense, and is tumoricidal and microbicidal along with its metabolites, NO~2~^−^ and NO~3~^−^. However, over-production of NO becomes a key mediator of tissue damage (Nathan [@CR131]; Pendino et al. [@CR140]; Kroencke et al. [@CR90]). JYH and SYH could inhibit TNF-α, nuclear factor (NF)-κB, IL-(1β, 6, 8) secretion and NO production significantly and enhance IL-10 expression below 0.4 mg kg^−1^ in vitro and in vivo, thereby showing anti-inflammatory activities (Kao et al. [@CR85]; Li et al. [@CR115]; Feng and Li [@CR42]). However, reported pharmacological studies showed no significant difference in anti-inflammatory activity of JYH and SYH.

In trypsin-induced mast cell, Kang confirmed that water extraction of JYH (10, 100 and 1000 μg mL^−1^) could inhibit trypsin-induced extracellular signal-regulated kinase (ERK) phosphorylation and did not affect the trypsin activity even at the concentration of 1000 μg mL^−1^, indicating JYH inhibition of trypsin-induced mast cell activation through inhibiting ERK phosphorylation rather than trypsin activity in vitro (Kang et al. [@CR84]). Li compared the inflammatory activities of water extractions of JYH and SYH with 1 μM Dexamethasone (DEX) as positive control. Both JYH (0.1532, 1.532, 15.32, 153.19, 306.38, 612.77 μg mL^−1^) and *L. macranthoides* (0.1645, 1.645, 16.45, 164.54, 329.08, 658.16 μg mL^−1^) exerted anti-inflammatory activity, but *L. macranthoides* showed a stronger inhibitory intensity of TNF-α and IL-6 secretion than JYH did (*P* \< 0.05) (Li et al. [@CR115]). However, this study lacked content consistency, which further compromised the accuracy of results.

In another study, LPS-induced acute lung inflammation mice were administered with different concentrations of JYH water extraction (0.4 mg kg^−1^, 4 mg kg^−1^ and 40 mg kg^−1^) orally for 24 h. Then, the cytokine concentrations (TNF-α, IL-1β, IL-10 and IL-6) in the bronchoalveolar lavage fluids (BALF) were measured by enzyme-linked immunosorbent assay (ELISA). The results showed that JYH had protective activity against LPS-induced lung inflammatory cytokine releasing in vivo (Kao et al. [@CR85]). All these studies suggested that both JYH and SYH could inhibit inflammatory reaction, but few studies compared them systematically and then told their similarities or differences.

The studies regarding anti-inflammatory activity of JYH in preparations are abundant, while studies of that on SYH are limited. Cheng studied anti-inflammatory activities of a traditional herbal formula which was consisted of Rosae Multiflorae Fructus and JYH (50:30, V/V) in LPS-stimulated RAW 264.7 macrophages. Ethanol extraction of this formula (containing JYH 5 mg mL^−1^) dose-dependently inhibited NO, IL-6, TNF-α productions and cellular iNOS protein, COX-2 expressions by the NF-κb and mitogen-activated protein kinases (MAPKs) signalling pathways in vitro (Cheng et al. [@CR27]). Gingyo-san (1 mg kg^−1^, water extraction), a traditional Chinese medicinal formula which includes JYH could reduce acute lung inflammation in LPS-induced lung inflammation mice compared with the control mice (*P* \< 0.05) by reducing the infiltration of activated polymorphonuclear neutrophils in the airways, decreasing pulmonary edema, reducing nitrosative stress, and improving lung morphology in vivo through administered it orally. The mechanism of anti-inflammatory activity of Gingyo-san was attenuating expressions of TNF-α, IL-1, IL-6, and activating NF-κB in BALF and lung tissue. Particularly, Gingyo-san also enhanced the expression of IL-10 (Yeh et al. [@CR223]).

Bacteriostatic activity {#Sec16}
-----------------------

JYH and SYH have similar antibacterial spectrum, and their water extractions could inhibit *Escherichia coli*, *Shigellosis, Bordetella pertussis*, *Sarcina lutea*, *Bacillus subtitles*, *Mycobacterium tuberculosis*, *Staphylococcus*, *Pseudomonas aeruginosa*, *Streptococcus*, *Diplococcus pneumoniae*, etc. effectively (40 g kg^−1^) (Lei et al. [@CR104]). However, the antibacterial intensity of JYH was stronger than that of SYH (Shi et al. [@CR161]; Lei et al. [@CR104]), and there was a highly positive relationship (R^2^ = 0.73--0.93) between antibacterial activity and the content of phenolic acids (Shan et al. [@CR155]). What's more, phenolic acids, reaching the highest concentration in the tissues of digestive tract, particularly the oral mucosa, have strong effect to prevent oral diseases (Petti and Scully [@CR143]). Thereby, regular consumption of JYH and SYH may help prevent oral diseases.

Using a bacterial model (*P. aeruginosa*), the relationship of antibacterial activities between JYH and SYH (70% ethanol extractions) was evaluated. The antibacterial activities of JYH and SYH should be divided into two clusters by multivariate statistical analysis, and the results supported the disaggregation of JYH and SYH by the Pharmacopoeia Committee. Meanwhile, the inhibition effects of JYH (100 mg mL^−1^) on *P. aeruginosa* were similar regardless of geographical origins. In contrast, the inhibition effects of SYH (100 mg mL^−1^) on *P. aeruginosa* were not stable, indicating JYH a more stable quality and activity (Shi et al. [@CR161]).

Antiviral activity {#Sec17}
------------------

JYH was the most popular herb used in treatments of severe acute respiratory syndromes (SARS) and influenza A in 2003 and 2009 (Yang et al. [@CR219]). Phenolic acids were regarded as main antiviral compounds of JYH and SYH. According to Wang's study, 60% ethanol extractions of both JYH (1 mg mL^−1^) and SYH (1 mg mL^−1^) could inhibit the infection of Newcastle Disease Virus (NDV), but there was no significant difference between them (*P* \> 0.05). Flavonoid extractions (extracted by 70% ethanol) of JYH (1 mg mL^−1^) and SYH (1 mg mL^−1^) had significant antiviral activities against pseudorabies virus (PRV) in vitro, between which SYH had stronger inhibitory effect on PRV (Wang et al. [@CR193]; Wang et al. [@CR194]).

Liver protective activity {#Sec18}
-------------------------

Acetaminophen (AP)-induced hepatotoxicity was the most common acute liver injury in both the United States and the United Kingdom (Lee [@CR97]; Zhou et al. [@CR242]). To date, JYH, *L. macranthoides* and *L. fulvotomentosa* have already been confirmed liver protective activities through various in vitro and in vivo trials (Jiang et al. [@CR78]; Sun et al. [@CR171]; Shi and Liu [@CR158]), and there was no significant difference in liver protective activities between them (Tang et al. [@CR174]).

On one study, by TdT-mediated biotin-dUTP nick-end labeling (TUNEL) assay, Jiang found that AP increased the number of apoptotic hepatocytes in mice (*P* \< 0.001), while JYH (350 mg kg^−1^, water extraction, administered orally) obviously decreased this tendency (*P* \< 0.001). *N*-Acetylcysteine (NAC, 600 mg/kg as positive control) chould also obviously ameliorate AP-induced liver injury. Detected by cell viability (CV) assay, AP-induced cytotoxicity in human normal liver L-02 cells could be reversed by CGA **(1)**, isochlorogenic acid A--C **(3--5)** and CA **(62)** of JYH, while flavonoids \[cynaroside **(88)**, luteolin **(89)**, hyperoside **(130)**\], iridoids (swertiamarin) and essential oils \[linalool **(295)** and geraniol **(325)**\] had no protective activities against AP-induced hepatotoxicity. Thus, JYH could prevent AP-induced liver injury in vivo by inhibiting apoptosis, and phenolic acids may be the main hepato-protective active compounds in JYH (Jiang et al. [@CR78]). What's more, phenolic acids alleviating AP-induced hepatotoxicity could also prevent liver injury induced by various chemical compounds such as carbon tetrachloride and thioacetamide (Wu et al. [@CR203]; Mancini-Filho et al. [@CR128]). On the other study, SYH saponins were reported to exert protective activities on liver injury in vitro and in vivo caused by acetaminophen, Cd, and CCl~4~ distinctly (Ferrazzano et al. [@CR45]; Ji et al. [@CR73]). In [d]{.smallcaps}-aminogalactose and CCl~4~-induced liver injury rats, water extractions of both *L. macranthoides* and *L. fulvotomentosa* (150 mg kg^−1^) showed liver protective activities (Shi et al. [@CR159]). These results revealed that JYH and SYH had potential to be developed as a new drug against liver injury. However, these studies lacked positive control and further studies require more in-depth, including exploring the related pathways and searching for the targets.

Antioxidative activity {#Sec19}
----------------------

Phenolic acids are well-known antioxidants used as nutritional supplements to enhance the antioxidative capacity of body (Jiang et al. [@CR78]). CGA **(1)** and CA **(62)** are powerful antioxidants in vitro and in vivo (Wang et al. [@CR190]). Flavonoids, especially cynaroside **(88)** which can remove free radicals of ultra oxygen ions in body could increase immunity and delay senescence (Yang et al. [@CR219]). Antioxidative activity of JYH presented a significant positive correlation with the content of CGA **(1)**, cynaroside **(88)**, rutin **(125)** and hyperoside **(130)** (Kong et al. [@CR89]). Studies on antioxidative activity of SYH also focus on its phenolic acids and flavonoids (Xu et al. [@CR215]). So far, various pharmacological studies have confirmed potent antioxidative activities of JYH and SYH in vitro and in vivo (Chen et al. [@CR23]; Shang et al. [@CR157]; Guo et al. [@CR54]; Xu et al. [@CR215]). What's more, SYH may have higher antioxidative intensity than that of JYH according to the current research (Xiao et al. [@CR209]). 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic) acid (ABTS+) scavenging assay is the most frequently used antioxidative activity assay for it could measure antioxidative activity in a rapidly and directly simple manner (Lee et al. [@CR102]).

JYH {#Sec20}
---

Seo measured antioxidative activities of 70% methanol extractions of JYH (25, 50, 100, 250, 500, and 1000 mg L^−1^) by ABTS+ and reducing power (RP) assays, with butylated hydroxytoluene (BHT, 25, 50, 100, 250, 500, and 1000 mg L^−1^) as a positive control. The ABTS+ assay suggested JYH a significantly stronger antioxidative activity than BHT in vitro (*P* \< 0.05) (Seo et al. [@CR154]). Injectable SHL has been demonstrated antioxidative activity. In LPS-induced acute lung injury mouse, superoxide dismutase (SOD) and catalase (CAT) activities were markedly decreased, while malondialdehyde (MDA) was over-production. In contrast, injectable SHL (5 and 10 mL kg^−1^) could decrease MDA content and the over-production of pro-inflammatory cytokines (TNF-*α* IL-1*β*, and IL-6) in vivo. What's more, 10 mL kg^−1^ SHL increased the SOD and CAT activities (*P* \< 0.05). Histological studies demonstrated that SHL attenuated LPS-induced interstitial edema, hemorrhage, and the infiltration of neutrophils into lung tissue (Fang et al. [@CR40]).

SYH {#Sec21}
---

Employing pyrogallol autoxidation and Fenton assays, Xu determined the free radicals scavenging ability of SYH flavonoids (extracted by 70% ethanol) in vitro, and measured the protective activity of SYH flavonoids on hydrogen peroxide-induced (H~2~O~2~-induced) oxidative injury endothelial cells and cardiomyocytes by methyl thiazolyl tetrazolium assay. The scavenging rates of superoxide anion free radical (O~2~^−^·) and hydroxy free radical (·OH) were 42.40% and 64.99% respectively when the concentration of SYH flavonoids was 250 μg mL^−1^. With SYH flavonoids pretreating, the survival rates of H~2~O~2~-induced oxidative injury endothelial cells and cardiomyocytes were upgraded to 60.45% and 69.98% (Xu et al. [@CR215]), showing high antioxidative activities in vitro, similar conclusion with (Wu et al. [@CR206]; Xiao et al. [@CR209]).

Using different solvents, the antioxidative activities of SYH may be different. Hu used in vitro antioxidative assays, ABTS+ and O~2~^−^· assays, as well as FRAP assay being selected to obtain complementary results, to evaluate different antioxidative activities of *L. macranthoides* (100 g L^−1^) extracted by different solvents. The results showed n-butanol fraction had the highest ABTS+ and O~2~^−^· scavenging activities among water extraction, petroleum ether, ethyl acetate and n-butanol fractions (Hu et al. [@CR63]).

The above studies show that both JYH and SYH possess potent antioxidative activities, suggesting them potential natural antioxidants in scavenging biologically relevant radicals. However, further researches should focus on evaluating their antioxidative activities in vivo and elucidating the antioxidant mechanism. Moreover, the differences of their antioxidative intensities are also worthy of further study.

Hypoglycemic activity {#Sec22}
---------------------

Diabetes mellitus (DM) a chronic metabolic disorder has become one of the world's most serious health concerns. Clinically, there are four types of DM, and type 2 diabetes mellitus (T2DM) is the most common form that causes many severe secondary complications, such as atherosclerosis, renal dysfunction and failure, cardiac abnormalities and ocular disorders (Rengasamy et al. [@CR150]; Wang et al. [@CR198]; Guo et al. [@CR55]). Shin's study showed that CGA **(1) (**10 and 20 mg kg^−1^, intraperitoneal injection) effectively preserved the expression of tight junction protein and attenuated STZ-induced diabetic retinopathy in mice (Shin et al. [@CR162]). Nowadays, JYH has already been an ingredient of hypoglycemic CPMs for T2DM, and SYH has also been mentioned to be a potential therapy for T2DM.

In streptozocin (STZ)-inducd diabetic rats, the food and water intake and the levels of sugar and insulin were drastically decreased after orally administrating with water extraction of JYH or SYH (all 800 mg kg^−1^). What's more, the contents of liver and skeletal muscle glycogen and the concentrations of hepatic pyruvate kinase and hexokinase increased, together with significant declining of total cholesterol, totaltriglyceride, low-density and very-low-density lipoprotein-cholesterin and significant rising of high-density lipoprotein-cholesterin, indicating JYH and SYH notable hypoglycemic activities in vivo (Wang et al. [@CR200]; Zhao et al. [@CR237]).

Present studies showed that JYH and SYH exerted similar hypoglycemic activities, inspiringly, future researches asking more exploring of their differences and bringing into positive control.

Anti-tumour activity {#Sec23}
--------------------

JYH and SYH have already been confirmed anti-tumour activties on human hepatoma HepG2 cell, HL-60, U-937, Jurkat, ovarian cancer A2780, K-562 in vitro and in vivo (Park et al. [@CR138]; Guan et al. [@CR51]; Shan et al. [@CR156]). CA **(62)** and its derivatives could suppress tumor angiogenesis and retard tumor growth (Jung et al. [@CR81]). Among them, CGA **(1)**, a well-known anti-tumour agent could up-regulate cellular antioxidant enzymes and suppress the ROS-mediated activation of NF-κB, activator protein-1, and MAPK (Feng et al. [@CR43]). By inhibiting Akt and activating MAPKs, JYH polyphenolic extraction (10 mg mL^−1^, extracted by 70% methanol) could inhibit proliferation of human hepatoma HepG2 cell line in vitro in a dose-dependent manner (Park et al. [@CR138]). In recent years, macranthoside B **(267)**, a hederagenin saponin in SYH showed great potential to be an anti-tumour agent for its capability of blocking cell proliferation and inducing cell death in several types of cancer cells through the caspase-mediated pathways, such as caspase-3 and caspase-9 in vitro and in vivo (Shan et al. [@CR156]; Guan et al. [@CR51]; Wang et al. [@CR191]). Employing cell proliferation and xenograft tumor growth assays, Wang confirmed the anti-tumour activity of macranthoside B **(267)** both in vitro and in female athymic BALB/cA nude mouse, with IC~50~ value of 10.10 ± 0.93 μM.

Other activities {#Sec24}
----------------

In addition to the pharmacological activities described above, JYH and SYH displayed other activities. Water extraction of JYH (100, 200 mg kg^−1^, orally administered) could inhibit the increasing retinal vessels in both outer and inner plexiform layers in STZ-induced diabetic mice. Furthermore, it could reduce the increasing cell proliferation and tube formation induced by vascular endothelial growth factor (VEGF) in FR/6A cells with no cytotoxicity, showing inhibition property of JYH against VEGF-induced retinal angiogenesis in vitro (Zhou et al. [@CR241]). Conversely, anti-angiogenic activity of SYH needed to be explored further. Xanthine oxidase (XO) is an enzyme related to hyperuricaemia. Employing enzymatic assay, Peng evaluated the XO inhibition activity of *L. macranthoides* water extraction in vitro. *L. macranthoides* extraction showed inhibition activity on XO with an IC~50~ value of 58.2 μg mL^−1^. Isochlorogenic acid A--C **(3--5)** with dicaffeoyl groups exhibited effective XO inhibition with IC~50~ values of 189.6 ± 7.9, 96.2 ± 3.1 and 75.3 ± 2.6 μM, while compounds **(1**, **2**, **6)** with monocaffeoyl group showed weak XO inhibitory activities (10--15% inhibition at the concentration of 200 μM) (Peng et al. [@CR142]).

Clinical use {#Sec25}
============

Clinical indications of JYH and SYH are mainly related to inflammation, bacterial and virus infection. There are numerous clinical trials on JYH products and most of them focus on SHL. On the contrary, clinical studies on SYH remain rare.

Significant therapeutic effects on oral ulcer were taken by a standard double therapy with Ranitidine (0.15 g × 4/day) and Vitamins (20 mg × 3/day Vitamin B, 200 mg × 3/day Vitamin C) (RcV) or SHL Oral Liquid (20 mL × 3/day, equivalent to JYH crude drug 7.5 g/day) (RcS) (120 cases). Patients with RcS treatment showed to achieve higher rates of effectiveness (*P* \< 0.05) than those with RcV. Immunoglobulin G and secretory immunoglobulin A levels of patients treated with RcS were better than those treated with RcV, promoting a healing of ulcer and improving the clinical symptoms of patients (Ying et al. [@CR224]). The effect of JYH decoction combined with penicillin on the treatment of syphilis was assessed. In this study, a total of 92 syphilis patients were divided into two groups to treat with either penicillin injection~i.m~ (2,400,000 U kg^−1^ d^−1^, 1 times/week) or a combination of JYH decoction (30 g/day) and penicillin injection (PcJ) for 3 weeks. After the 3 months of treatment, the Th1/Th2 levels of PcJ group were significantly improved and IL-2, IL-8 and IL-10 were significantly decreased. These changes were statistically significant in comparison with the penicillin group (Zhao and Li [@CR236]). Gao took SHL Oral Liquid (for children. 1--3 years old, 10 mL, tid; \> 3--7 years old, 20 mL) combined with Recombinant Human Interferon α-2b injection (RHi, 100,000 U kg^−1^ d^−1^) to treat children viral pneumonia (7 days of treatment, 55 cases). In comparison to using RHi alone, a combination with SHL Oral Liquid possessed higher effective rates, and antipyretic time as well as cough disappearance time was significantly shortened. What's more, the adverse reaction rates of them two showed no significant differences (*P* \> 0.05) (Gao [@CR46]). Wu took Fusidic Acid Cream (2 mm) as the control group and JYH decoction (30 g) combined with Fusidic Acid Cream (2 mm) as experimental group to analyze the clinical efficacy of JYH decoction in the treatment of targeted drugs-induced rash (80 cases). After treatment, the effective rates of experimental group (95.00%) were higher than those of control group (77.50%) (*P* \< 0.05), and no statistical differences of adverse reaction rates were found between the two groups (*P* \> 0.05) (Wu et al. [@CR208]).

The above results showed JYH a high clinical application value. It could relieve the clinical symptoms effectively, and improve the quality of life. However, are these satisfactory clinical traits a placebo effect? Further study involving placebo group might help in the identification of work effort for JYH.

Quality control {#Sec26}
===============

Quality control of herbs is essential to ensure their efficiency and safety. According to 2015 Edition ChP, the content of CGA **(1)** and cynaroside **(88)** in JYH must be no less than 1.5% and 0.05%, and the content of CGA **(1)** and the total amount of macranthoidin B **(266)** and dipsacoside B **(269)** in SYH must be no less than 2.0% and 5.0% on the basis of high performance liquid chromatography (HPLC) calibration Standard Operating Procedure. However, current studies suggested that habitats, harvest time, extract methods may bring about differences in quality of herbs to some extent (Table [8](#Tab8){ref-type="table"}). According to Table [8](#Tab8){ref-type="table"}, GCD has a stable quality, and high-yield harvest phases of JYH should be S3-S5, just before the beginning of summer. Meanwhile, tetraploid JYH is an excellent breed for agricultural cultivation with high yields, stress tolerance and good quality. In daily storage of JYH and SYH, environment should keep cool due to some of their chemical compounds are thermosensitive (Lei et al. [@CR105]; Wang et al. [@CR195]; Ji et al. [@CR72]).Table 8Factors influencing quality of JYH and SYHFactorsJYHSYHLikely reasonsReferencesHabitatsGCD has a stable qualityMay relate to the sunshineLi et al. ([@CR113]), Chen et al. ([@CR16]), Yang et al. ([@CR219])PloidyTetraploid JYH has higher polyphenol contents, biomass yields, stronger resistance to drought and higher antioxidant activities than those in diploid JYHIncreases in gene dosage follow the plant genome duplications in nucleus. This process may not only bring about significant changes in morphology and physiology, but also increase the cell size and the content of secondary metabolites because of whole genome duplications. Herbs are especially significant, with growth rates enhancing and genetic quality improvingLavania ([@CR95]), Sun et al. ([@CR172]), Van Laere et al. ([@CR184]), Kaensaksiri et al. ([@CR82]), Lavania et al. ([@CR96]), Kong et al. ([@CR89]), Gao et al. ([@CR48]), Li et al. ([@CR112]), Li et al. ([@CR109]), Li et al. ([@CR111]), Xiong et al. ([@CR212])Harvest timeThe content of essential oils reaches the highest at S5, while the content of flavonoids reaches the highest at S3, and CGA is at S3 and S4Yang et al. ([@CR220]), Kong et al. ([@CR89])Extraction methodsExtraction yields of phenolic acids in JYH are associated with ethanol concentrationHydrodistillation is the best choice to extract pure volatile fractionEthyl acetate fraction exhibited the highest content of total phenolic acids and total flavonoidsDuan et al. ([@CR37]), Hu et al. ([@CR63]), Wu et al. ([@CR205])

Traditionally, herbs are identified by morphological characteristics which primarily depend on human expertise. In some case, it is extremely difficult to definitively identify plant origins. With the development of chemical analysis, measuring an herb or CPMs rapidly and multi-content has become a consensus. Previous studies have provided JYH numerous reliable quality control methods. Yang used near infrared (NIR) spectroscopy technique combined with synergy interval partial least squares and genetic algorithm to monitor extraction process of JYH. This method reliably monitored changes in the content of online extract process (Yang et al. [@CR220]). NIR spectra could also reflect the differences between batches. Li built an NIR fingerprint method, and proposed to use it in consistency check between batches, beneficial to industrial production (Li et al. [@CR113]). Nevertheless, studies of quality control in SYH are limited, and most of them focus on distinguishing SYH from JYH, lacking researches on SYH exclusively.

JYH and SYH could be distinguished by normal light microscopy combined fluorescence microscopy. Under normal light microscopy, JYH and three origins of SYH (except *L. confusa*) could be distinguished by their traits of glandular hairs. By means of fluorescence microscopy, *L. confusa* was further identified with its transverse section partially distributing fluorescence materials (Chu et al. [@CR29]). Through ultra HPLC with triple quadrupole mass spectrometry technology, cynaroside **(88)**, sweroside **(143)**, macranthoidin A **(265)**, macranthoidin B **(266)** and dipsacoside B **(269)** have been quantified as internal standard substances to check SYH adulterated in JYH preparations. The results showed that JYH could be easily distinguished from SYH by the total amount of saponins (0.067 mg g^−1^ for JYH and \> 45.8 mg g^−1^ for SYH).

Han used DNA barcoding, a molecular diagnostic technology identifying species by a short genomic sequence (Hebert et al. [@CR59]), to investigate the varieties and proportions of adulterant species. The results indicated that ITS2 barcodes could be used to identify adulterants and JYH was one of the most adulterant species. Notably, given that some samples were heavily processed and there was no DNA barcoding in artificial adulterant sample, DNA barcoding technology was not sufficient to identify any given samples. In other words, DNA barcoding technology could be used to establish the authenticity of herbs or CPMs, but could not be used to evaluate the quality of herbs or CPMs (Han et al. [@CR56]). Employing the modified cetyl trimethyl ammonium bromide method, genomic DNA was isolated from Fu Fang Yu Xing Cao Tablet, Lin Yang Gan Mao Tablet and Yin Qiao Jie Du Tablet (names of CPMs), which all contained JYH. Jiang used sequence and phylogenetic analyses to detect the species in prescriptions and the results showed that the above three CPMs were actually adulterated with SYH. Jiang's method was reproducibility and had characteristic of non-reliance on morphology, so it could be used in authenticating preparations so as to evaluate their quality (Jiang et al. [@CR77]).

Nowadays, SYH adulterated in JYH is common. According to Zhang's study, eighteen of twenty one JYH preparations were adulterated with SYH in proportions of 11.3--100% (Zhang et al. [@CR234]). Gao checked twenty extractions and 47 CPMs. The results showed that only 12 extractions and 33 CPMs were authentic. What's more, Gao's study revealed that some CPMs containing SYH were actually adulterated with high commercial value JYH, which indicated that the manufacturers may not distinguish JYH and SYH, giving a risk to a loss of revenue (Gao et al. [@CR48]).

Above all, future research should value SYH in order to identify JYH and SYH better both in crude materials or CPMs.

Toxicology {#Sec27}
==========

To date, the toxicity studies on JYH are seldom reported, while those on SYH are relatively more. Studies on the toxicology of JYH and SYH are mainly focused on saponins. However, neither JYH nor SYH water extractions have significant toxicity on breathing, blood pressure or urine output (the half lethal dose (LD~50~) \> 110 g kg^−1^), far higher than their biologically active dose (Jiang et al. [@CR79]; Thanabhorn et al. [@CR176]). According to 2015 Edition ChP, the clinical administrations of JYH or SYH in an adult are suggested to be 6--15 g daily, indicating them low-toxicity herbs.

Wang researched hemolysis of macranthoidin B **(266)** and dipsacoside B **(269)** in vitro and in vivo. By observing hemolysis of them in rabbit red blood cells at the concentration of 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 mg L^−1^, no hemolysis occured compared to the control group (*P* \> 0.05). In vivo, macranthoidin B **(266)** (0.110 and 0.055 mg g^−1^) and dipsacoside B **(269)** (0.020 and 0.010 mg g^−1^) did not cause hemolysis (continuous tail vein administration for 7 days) (Wang et al. [@CR199]). In another study, loniceroside A **(236)**, loniceroside B **(237)** (the major saponins in JYH), macranthoidin A **(265)**, dipsacoside B **(269)** and dipsacoside VI **(270)** (the major saponins in SYH) all did not cause hemolysis at the concentration of 1.0 mg mL^−1^ in vitro. The hemolysis rate of macranthoidin A **(265)** rose with its concentration increasing. No hemolysis occurred when the concentration of macranthoidin A **(265)** was 0.6 mg mL^−1^, and the hemolysis rate was 50.4% when the concentration of macranthoidin A **(265)** reached 1.0 mg mL^−1^. When comes to the hemolysis of JYH compounds, the strength decreased as the following order, saponins, phenolic acids, iridoids. When the concentrations of iridoids were 0.1--1.2 mg mL^−1^ or phenolic acids was less than 1.0 mg mL^−1^, no hemolysis occurred. However, hemolysis occurred when the concentration of saponins was 0.6 mg mL^−1^, and the hemolysis rate rose rapidly with the concentration further increasing. The hemolysis rate was 55.3% when the concentration of saponins in JYH reached 1.2 mg mL^−1^. Last but not least, the results showed that there were no significant differences in hemolysis between JYH representative compounds and SYH representative compounds in rabbit red blood cells (*P* \> 0.05) (Huang et al. [@CR66]). Additionally, *L. macranthoides* 70% ethanol extraction (5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 mg L^−1^) and JYH extraction (0.5 g mL^−1^) did not cause hemolysis in vitro (Wang et al. [@CR199]; Dai et al. [@CR33]). In brief, hemolysis of JYH and SYH may be closely related to saponins, although the hemolysis strength of saponins was not strong (*P* \> 0.05). The hemolysis of SYH may be related to the inclusion of macranthoidin A **(265)** in some of its plant origins.

However, there are contrary opinions about their toxicology. SYH contains more saponins than JYH. The potential security risk of SYH should be higher than that of JYH. The release rate of β-hexosaminidase of SYH water extraction (1.46 g kg^−1^) was higher than that of JYH water extraction (1.25 g kg^−1^) in vitro. SYH water extraction was more likely to stimulate the degranulation of basophilic mast cells than JYH water extraction. Thereby, the allergic reaction of SYH water extraction was more severe than that of JYH water extraction (Zhang [@CR231]). Additionally, about four hundred million patients are treated with traditional Chinese medicine injections (TCMI) in China per year. Among TCMI, intravenous SHL has the highest risk of injection-induced immediate hypersensitivity reactions (IHRs). IHRs were attributed to the intermediate fraction F2 coming from JYH and Forsythiae Fructus in SHL injection. In Gao's study, Balb/c mice were intravenously injected with the SHLI (0.5 mL/mouse), F1 (the extraction of Scutellariae Radix, 4.81 mg/mouse), or F2 (16.5 mg/mouse), respectively. Thirty minutes later, the rectal temperature was measured. F2 contributed to obvious hypothermia, while F1 has no effect on the mouse's temperature. After intravenously injecting with 5 mg mL^−1^ Evans Blue (1 mL), a representative image of Evans Blue extravasation of mouse paw was observed in F2 group. In brief, JYH for injection use exerts a safety risk (Gao et al. [@CR49]).

In summary, JYH and SYH were found to be fairly nontoxic, for such above high concentrations no longer having toxicological meaning.

Conclusion {#Sec28}
==========

*L. japonica* (also known as JYH, honeysuckle and Rendong) was traditionally utilized for clearing heat, detoxicating and expelling exopathogenic wind-heat. According to TCM theory, the above functions are closely associated with the treatment of inflammation or various infectious diseases. From the view of TCM, JYH belongs to cold nature, and it is the main drug to cure sore, heat-toxin and seasonal febrile disease, suggesting JYH an herb of treating inflammation. In light of its long traditional use to cool blood and relieve dysentery, the relationship between the traditional use and modern therapy of JYH against virus has also been established. However, SYH is more likely for local use only. The correlation between modern usage and traditional use of SYH remains unclear. More investigations of ethnomedicinal remedies of SYH should been conducted. These findings are crucial for a better understanding of the alternative strategy of JYH and SYH and to help in the authentication of them. In brief, the traditional uses of JYH have already been substantiated by modern pharmacological studies. In Asia, JYH and SYH are often used as tea. As the above said, bioactive components (especially CGA) of them have already been deeply explored. Due to the good and positive related anti-inflammatory, antiviral and antibacterial activities, CGA was used as marker to evaluate the chemical quality of JYH and SYH. However, CGA was not specificity or even ubiquitous. Thereby employing CGA to control the quality of JYH and SYH is really exclusive or accurate? This should be studied further.

In this review, we systematically summarize knowledge on botanies, ethnopharmacology, phytochemistry, pharmacological activities, clinical use, quality control and toxicology of JYH and SYH. To date, 326 and 148 compounds have been found in JYH and SYH, respectively. phenolic acids, the major compounds presenting in JYH and SYH are similar and bioactive, with multiple bioactivities being revealed. However, reported literature showed that the main chemical differences between JYH and SYH are concentrated on saponins, such as macranthoidin A--B **(265**, **266)**, macranthoside A--B **(267**, **268)** and dipsacoside B **(269)**, and this cluster of compounds is anticipated to get more in-depth studies in anti-tumour compounds exploitation. As far as pharmacological studies of JYH and SYH, many in vitro and in vivo experiments demonstrate that they are pharmacologically similar, but also differ in some aspects. For instance, JYH is more powerful in antibacterial activity than SYH, while SYH possesses a higher intensity than JYH in antioxidative activity. What's more, neither JYH nor SYH exert significant toxicity, but some studies indicated that the hemolysis of JYH and SYH was closely related to saponins, thereby SYH showing a higher safety risk. Given that SYH contains a large amount of saponins and the toxicological mechanism remains unclear, careful consideration should be given to the use of SYH in high-risk preparations.

However, gaps still exist in the scientific studies on them. Therefore, we provide several topics which should have priority for further detailed investigation. Firstly, there are not enough phytochemistry studies on SYH. Although phenolic acids and saponins are considered as the major bioactive compounds in SYH, the investigation of other ingredients like iridoids and flavonoids is still in a shortage, which severely limited the application diversity of SYH, and the chemical difference between JYH and SYH remains unclear. Secondly, current pharmacological studies on SYH are not available to validate its difference with JYH, bringing about continuing debate. Further investigation should be performed preferentially with comparing their activity intensities in vitro and in vivo, and introduced positive control. Finally, JYH and SYH are recognized as nontoxic herbs, but few toxicological studies support the safety of them in patients with underlying diseases, especially in elderly, children and pregnant women. The potential hemolysis risk of SYH should not be ignored, and it is worth investigating its interchangeability with JYH in injection.

In conclusion, it is necessary to accelerate the phytochemistry and pharmacological studies of SYH, and figure out its difference and similarity with JYH more in-depth. Future direction of research should pay attention to accurate and rapid authentication of JYH and SYH for it is crucial to ensure the safety and function of medicinal or edible herbs as well as their preparations. Additionally, more efforts deserve to gain insights into the toxicological actions of JYH and SYH.
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